{"content":"<li class=\"n-box-item date-title\" data-end=\"1554868799\" data-start=\"1554782400\" data-txt=\"Monday, December 23, 2019\">Tuesday, April  9, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3449494\" data-ts=\"1554848857\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IZEA\" target=\"_blank\">IZEA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449494-izeaplus-17_6-after-double-digit-bookings-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IZEA +17.6% after double-digit bookings growth</a></h4><ul>   <li>IZEA Worldwide (NASDAQ:<a href='https://seekingalpha.com/symbol/IZEA' title='IZEA Worldwide, Inc.'>IZEA</a>) is <font color=\"green\">up 17.6%</font> in postmarket trading after it reported <a href=\"https://seekingalpha.com/pr/17471490-izea-reports-q1-bookings-7_8-million-18-percent-yoy\" target=\"_blank\">first-quarter bookings that rose 18%</a> year-over-year.</li>    <li>The online marketplace firm posted bookings of $7.8M vs. $6.6M a year ago.</li>    <li>Some 38% of those bookings came from a combination of software licensing and marketing spend, the company says, and software investments are paying off, CEO Ted Murphy says.</li>    <li>\u201cSaaS Licensing Bookings increased 1,124% from Q1 last year,\" he notes. \"Our SaaS licensing revenue committed under contract for 2019 is already 37% greater than that of all of 2018.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449494\" data-linked=\"IZEA +17.6% after double-digit bookings growth\" data-tweet=\"$IZEA - IZEA +17.6% after double-digit bookings growth https://seekingalpha.com/news/3449494-izeaplus-17_6-after-double-digit-bookings-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3449494-izeaplus-17_6-after-double-digit-bookings-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449492\" data-ts=\"1554848111\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APPS\" target=\"_blank\">APPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449492-digital-turbineminus-4-after-100m-mixed-shelf-registration\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Digital Turbine -4% after $100M mixed shelf registration</a></h4><ul>   <li>Digital Turbine (NASDAQ:<a href='https://seekingalpha.com/symbol/APPS' title='Digital Turbine, Inc.'>APPS</a>) is <font color=\"red\">4% lower</font> postmarket after the company filed a <a href=\"https://seekingalpha.com/filing/4440029\" target=\"_blank\">$100M mixed shelf registration</a>.</li>    <li>The company filed to offer any combination of common stock, preferred stock, warrants, debt securities and units.</li>    <li>It intends to use any proceeds for general purposes, which could include \"working capital, repaying, reducing or refinancing indebtedness, financing acquisitions of other companies that we believe will add to and/or expand our service offerings, repurchasing or redeeming our securities, investments, and capital expenditures.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449492\" data-linked=\"Digital Turbine -4% after $100M mixed shelf registration\" data-tweet=\"$APPS - Digital Turbine -4% after $100M mixed shelf registration https://seekingalpha.com/news/3449492-digital-turbineminus-4-after-100m-mixed-shelf-registration?source=tweet\" data-url=\"https://seekingalpha.com/news/3449492-digital-turbineminus-4-after-100m-mixed-shelf-registration\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449489\" data-ts=\"1554846597\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVAX\" target=\"_blank\">NVAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449489-novavaxplus-5_4-on-plan-to-present-resvax-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novavax +5.4% on plan to present ResVax data</a></h4><ul>   <li>Novavax (NASDAQ:<a href='https://seekingalpha.com/symbol/NVAX' title='Novavax, Inc.'>NVAX</a>) is <font color=\"green\">up 5.4%</font> postmarket after announcing that its head of research and development will <a href=\"https://seekingalpha.com/pr/17471525-novavax-scientific-leadership-present-rsv-maternal-immunization-program-phase-3-data\" target=\"_blank\">share data from its Phase 3 trial</a> of ResVax next week at World Vaccine Congress.</li>    <li>ResVax is its respiratory syncytial virus fusion protein recombinant nanoparticle vaccine. The study failed to meet its primary endpoint in February.</li>    <li>The company's Dr. Gregory Glenn will give an oral presentation in Washington; the company's chief medical officer, Dr. Louis Fries III, will also take part in a panel discussion on chronic obstructive pulmonary disease.</li>    <li>The oral presentation, titled \"Phase 3 and beyond: The RSV F nanoparticle vaccine for infants via maternal immunization,\" will come Tuesday, April 16 at 3:40 p.m. ET.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449489\" data-linked=\"Novavax +5.4% on plan to present ResVax data\" data-tweet=\"$NVAX - Novavax +5.4% on plan to present ResVax data https://seekingalpha.com/news/3449489-novavaxplus-5_4-on-plan-to-present-resvax-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3449489-novavaxplus-5_4-on-plan-to-present-resvax-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449488\" data-ts=\"1554845608\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449488-after-hours-movers-and-shakers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After hours movers and shakers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/ATAI' title='ATA Inc.'>ATAI</a> <font color=\"green\">+29.3%</font>. <a href='https://seekingalpha.com/symbol/MRTX' title='Mirati Therapeutics, Inc.'>MRTX</a> <font color=\"green\">+3.1%</font>. <a href='https://seekingalpha.com/symbol/KALA' title='Kala Pharmaceuticals, Inc.'>KALA</a> <font color=\"green\">+3.1%</font>. <a href='https://seekingalpha.com/symbol/HPE' title='Hewlett Packard Enterprise Company'>HPE</a> <font color=\"green\">+2.4%</font>. <a href='https://seekingalpha.com/symbol/PKD' title='Parker Drilling Company'>PKD</a> <font color=\"green\">+2.1%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/TWST' title='Twist Bioscience Corporation'>TWST</a> <font color=\"red\">-6.2%</font>. <a href='https://seekingalpha.com/symbol/PHAS' title='PhaseBio Pharmaceuticals, Inc.'>PHAS</a> <font color=\"red\">-6.1%</font>. <a href='https://seekingalpha.com/symbol/AJRD' title='Aerojet Rocketdyne Holdings, Inc.'>AJRD</a> <font color=\"red\">-3.9%</font><a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a> <font color=\"red\">-2.8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449488\" data-linked=\"After hours movers and shakers\" data-tweet=\"$AACG $MRTX $KALA - After hours movers and shakers https://seekingalpha.com/news/3449488-after-hours-movers-and-shakers?source=tweet\" data-url=\"https://seekingalpha.com/news/3449488-after-hours-movers-and-shakers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449297\" data-ts=\"1554845409\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449297-notable-earnings-wednesday-s-open\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Notable earnings before Wednesday\u2019s open</a></h4><ul><li><a href='https://seekingalpha.com/symbol/DAL' title='Delta Air Lines, Inc.'>DAL</a>, <a href='https://seekingalpha.com/symbol/MSM' title='MSC Industrial Direct Co., Inc.'>MSM</a></li><li>For Seeking Alpha's full earnings season calendar, <a href=\"https://seekingalpha.com/earnings/upcoming\" target=\"_blank\">click here</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449297\" data-linked=\"Notable earnings before Wednesday\u2019s open\" data-tweet=\"$DAL $MSM - Notable earnings before Wednesday\u2019s open https://seekingalpha.com/news/3449297-notable-earnings-wednesday-s-open?source=tweet\" data-url=\"https://seekingalpha.com/news/3449297-notable-earnings-wednesday-s-open\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449482\" data-ts=\"1554844070\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JBLU\" target=\"_blank\">JBLU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449482-jetblue-may-announce-trans-atlantic-routes-cnbc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JetBlue may announce trans-Atlantic routes - CNBC</a></h4><ul><li>JetBlue (NASDAQ:<a href='https://seekingalpha.com/symbol/JBLU' title='JetBlue Airways Corporation'>JBLU</a>) <font color=\"green\">+4%</font> after-hours following a CNBC report that the airline appears to be gearing up to <a href=\"https://www.cnbc.com/2019/04/09/jetblue-appears-to-be-gearing-up-to-announce-service-across-the-atlantic.html\" target=\"_blank\">announce service across the Atlantic</a> as soon as tomorrow, an expansion the company views an an opportunity to undercut entrenched rivals with its cheaper business-class service.</li><li>JBLU is scheduled to hold an \"all hands\" meeting with  staff at JFK Airport along with \"viewing parties\" at some of  its main hubs around the U.S. tomorrow afternoon, according to CNBC, citing an invitation it obtained.</li><li>The carrier reportedly may add service to London, but its plans could include other routes to European cities from its New York and Boston hubs.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449482\" data-linked=\"JetBlue may announce trans-Atlantic routes - CNBC\" data-tweet=\"$JBLU - JetBlue may announce trans-Atlantic routes - CNBC https://seekingalpha.com/news/3449482-jetblue-may-announce-trans-atlantic-routes-cnbc?source=tweet\" data-url=\"https://seekingalpha.com/news/3449482-jetblue-may-announce-trans-atlantic-routes-cnbc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449456\" data-ts=\"1554841396\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEVI\" target=\"_blank\">LEVI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449456-levisplus-2-after-1st-post-ipo-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Levi&#39;s +2% after 1st post-IPO report</a></h4><ul><li>Shares of Levi's Strauss (NYSE:<a href='https://seekingalpha.com/symbol/LEVI' title='Levi Strauss & Co.'>LEVI</a>) are <font color=\"green\">up 2.2%</font> in AH trading following the company's first earnings report in its return to the public market.</li><li>The company reported positive growth in the Americas (+9%) business, Europe (+3%) and Asia (+8%) during FQ1.</li><li>Gross margin was 54.6% of sales vs. 54.9% a year ago.</li><li>Looking ahead, Levi's expects constant-currency net revenues growth at at mid-single digits rate for the full year and constant-currency adjusted EBIT margin to be flat-to-slightly up.</li><li>Shares of Levi's are trading about 30% over where the IPO was priced.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3449441-levi-strauss-reports-q1-results\" target=\"_blank\">Levi Strauss reports Q1 results</a> (April 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3449456\" data-linked=\"Levi&#39;s +2% after 1st post-IPO report\" data-tweet=\"$LEVI - Levi&#39;s +2% after 1st post-IPO report https://seekingalpha.com/news/3449456-levisplus-2-after-1st-post-ipo-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3449456-levisplus-2-after-1st-post-ipo-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449453\" data-ts=\"1554841262\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PHAS\" target=\"_blank\">PHAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449453-phasebio-files-for-equity-offering-shares-down-6-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PhaseBio files for equity offering; shares down 6% after hours</a></h4><ul><li>PhaseBio Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/PHAS' title='PhaseBio Pharmaceuticals, Inc.'>PHAS</a>) has filed a <a href=\"https://www.sec.gov/Archives/edgar/data/1169245/000119312519101668/d730739ds1.htm\" target=\"_blank\">prospectus </a>for a public offering of 3M common shares. Pricing has yet to be determined.</li><li>Shares are off <font color=\"red\">6%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449453\" data-linked=\"PhaseBio files for equity offering; shares down 6% after hours\" data-tweet=\"$PHAS - PhaseBio files for equity offering; shares down 6% after hours https://seekingalpha.com/news/3449453-phasebio-files-for-equity-offering-shares-down-6-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3449453-phasebio-files-for-equity-offering-shares-down-6-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449439\" data-ts=\"1554840418\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTE\" target=\"_blank\">PTE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449439-polarityte-down-10-after-hours-on-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PolarityTE down 10% after hours on equity offering</a></h4><ul><li>PolarityTE (NASDAQ:<a href='https://seekingalpha.com/symbol/PTE' title='PolarityTE, Inc.'>PTE</a>) slips <font color=\"red\">10%</font> after hours in reaction to its public <a href=\"https://seekingalpha.com/pr/17471488-polarityte-announces-public-offering-common-stock\" target=\"_blank\">stock offering</a>. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449439\" data-linked=\"PolarityTE down 10% after hours on equity offering\" data-tweet=\"$PTE - PolarityTE down 10% after hours on equity offering https://seekingalpha.com/news/3449439-polarityte-down-10-after-hours-on-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3449439-polarityte-down-10-after-hours-on-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449432\" data-ts=\"1554840317\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSMT\" target=\"_blank\">PSMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449432-pricesmart-eps-in-line-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PriceSmart EPS in-line, misses on revenue</a></h4><ul><li>PriceSmart (NASDAQ:<a href='https://seekingalpha.com/symbol/PSMT' title='PriceSmart, Inc.'>PSMT</a>): Q2 Non-GAAP EPS of $0.88; GAAP EPS of $0.79 in-line.</li><li>Revenue of $854.43M (+1.8% Y/Y) <font color=\"red\">misses by $5.5M</font>.</li><li>Shares <font color=\"green\">+1.5%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17471489-pricesmart-announces-fiscal-2019-second-quarter-operating-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3449432\" data-linked=\"PriceSmart EPS in-line, misses on revenue\" data-tweet=\"$PSMT - PriceSmart EPS in-line, misses on revenue https://seekingalpha.com/news/3449432-pricesmart-eps-in-line-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3449432-pricesmart-eps-in-line-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449424\" data-ts=\"1554839927\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCG\" target=\"_blank\">PCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449424-wildfires-pg-and-e-s-next-big-risk-morgan-stanley-analyst-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More wildfires PG&amp;E\u2019s next big risk, Morgan Stanley analyst says</a></h4><ul><li><a href=\"https://www.barrons.com/articles/pg-e-stocks-next-risk-is-wildfire-liabilities-51554831285\" target=\"_blank\">Potential liabilities for future wildfire outbreaks</a> are the next worry for PG&amp;E (<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a> <font color=\"red\">-4.6%</font>) shareholders, Morgan Stanley warns in reiterating its Equal Weight rating and $17.50 price target.</li><li>\"Even a large insurance fund would, on its own, be insufficient to incentivize institutional investors to provide badly needed capital to PG&amp;E in the future,\" Stanley analyst Stephen Byrd writes.</li><li>While a wet winter may help to prevent a repeat of last year's disaster, the firm says fires are unlikely to disappear from the California landscape, and the state's inverse condemnation law means that companies could be on the hook for fires started by their equipment even if they are not found to be negligent.</li><li>Byrd notes the California Public Utilities Commission last week proposed a version of a stress test that would examine a utility's ability to weather a heavy financial blow and seeks to make sure utilities can help pay for fire damage without having their debt downgraded to junk, making it harder for them to raise funds.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449424\" data-linked=\"More wildfires PG&amp;E\u2019s next big risk, Morgan Stanley analyst says\" data-tweet=\"$PCG - More wildfires PG&amp;E\u2019s next big risk, Morgan Stanley analyst says https://seekingalpha.com/news/3449424-wildfires-pg-and-e-s-next-big-risk-morgan-stanley-analyst-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3449424-wildfires-pg-and-e-s-next-big-risk-morgan-stanley-analyst-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449422\" data-ts=\"1554838184\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AR\" target=\"_blank\">AR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449422-antero-resourcesminus-5-cowen-says-hedging-advantage-eroding\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Antero Resources -5% as Cowen says hedging advantage eroding</a></h4><ul><li>Antero Resources (<a href='https://seekingalpha.com/symbol/AR' title='Antero Resources Corporation'>AR</a> <font color='red'>-4.8%</font>) tumbles as Cowen initiates coverage with a <a href=\"https://thefly.com/thestreet/realmoney/index.php/ARid2890053/AR-Antero-Resources-initiated-with-a-Market-Perform-at-Cowen\" target=\"_blank\">Market Perform rating</a> and $11 price target, noting that as a higher-cost producer with excessive firm transportation, the firm sees more challenged returns beyond the highly hedged 2019 period that will make cash flow growth challenged into 2020, below $2.85/Mcf gas pricing.</li><li>With a less competitive free cash yield, the firm sees limited upside near-term.</li><li>At the same time, Cowen starts Cabot Oil &amp; Gas (<a href='https://seekingalpha.com/symbol/COG' title='Cabot Oil & Gas Corporation'>COG</a> <font color='green'>+0.9%</font>) with an <a href=\"https://thefly.com/thestreet/realmoney/index.php/COGid2890058/COG-Cabot-Oil--Gas-initiated-with-an-Outperform-at-Cowen\" target=\"_blank\">Outperform rating</a> and $32 price target, saying the company's Atlantic Sunrise pipeline project provides visibility to a solid growth outlook.</li><li>COG leverages one of the lowest cost structures among exploration and production companies and its margins continue to improve with pipeline additions, Cowen says.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449422\" data-linked=\"Antero Resources -5% as Cowen says hedging advantage eroding\" data-tweet=\"$AR $COG - Antero Resources -5% as Cowen says hedging advantage eroding https://seekingalpha.com/news/3449422-antero-resourcesminus-5-cowen-says-hedging-advantage-eroding?source=tweet\" data-url=\"https://seekingalpha.com/news/3449422-antero-resourcesminus-5-cowen-says-hedging-advantage-eroding\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>58&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449417\" data-ts=\"1554836976\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEGN\" target=\"_blank\">AEGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449417-aegion-subsidiary-awarded-5m-wastewater-rehabilitation-project\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aegion subsidiary awarded $5M wastewater rehabilitation project</a></h4><ul><li>Aegion (<a href='https://seekingalpha.com/symbol/AEGN' title='Aegion Corporation'>AEGN</a> <font color=\"red\">-2.5%</font>) subsidiary, Insituform Technologies, LLC has been <a href=\"https://seekingalpha.com/pr/17471321-aegion-subsidiary-awarded-5-million-wastewater-rehabilitation-project-phoenix-arizona\" target=\"_blank\">awarded</a> a contract valued at $5M from the City of Phoenix, Arizona to complete the rehabilitation of over 32 miles of 8- to 15-inch wastewater pipelines using Insituform® CIPP.</li><li>Work on the project is expected to begin in mid-2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449417\" data-linked=\"Aegion subsidiary awarded $5M wastewater rehabilitation project\" data-tweet=\"$AEGN - Aegion subsidiary awarded $5M wastewater rehabilitation project https://seekingalpha.com/news/3449417-aegion-subsidiary-awarded-5m-wastewater-rehabilitation-project?source=tweet\" data-url=\"https://seekingalpha.com/news/3449417-aegion-subsidiary-awarded-5m-wastewater-rehabilitation-project\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449413\" data-ts=\"1554836111\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FARO\" target=\"_blank\">FARO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449413-technology-movers-and-shakers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology movers and shakers</a></h4><ul><li><strong>Gainers: </strong>FARO Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/FARO' title='FARO Technologies, Inc.'>FARO</a>) <font color=\"green\">+18%</font>. Orion Energy Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/OESX' title='Orion Energy Systems, Inc'>OESX</a>) <font color=\"green\">+11%</font>. Cerner Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/CERN' title='Cerner Corporation'>CERN</a>) <font color=\"green\">+10%</font>. Fang Holdings (NYSE:<a href='https://seekingalpha.com/symbol/SFUN' title='Fang Holdings Limited'>SFUN</a>) <font color=\"green\">+8%</font>. SITO Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/SITO' title='SITO Mobile, Ltd.'>SITO</a>) <font color=\"green\">+8%</font>.</li> <li><strong>Losers: </strong>Pareteum Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>) <font color=\"red\">-8%</font>. Uxin (NASDAQ:<a href='https://seekingalpha.com/symbol/UXIN' title='Uxin Limited'>UXIN</a>) <font color=\"red\">-7%</font>. Summit Wireless Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/WISA' title='Summit Wireless Technologies, Inc.'>WISA</a>) <font color=\"red\">-7%</font>. DropCar (NASDAQ:<a href='https://seekingalpha.com/symbol/DCAR' title='DropCar, Inc.'>DCAR</a>) <font color=\"red\">-7%</font>. Maxar Technologies (NYSE:<a href='https://seekingalpha.com/symbol/MAXR' title='Maxar Technologies Inc.'>MAXR</a>) <font color=\"red\">-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449413\" data-linked=\"Technology movers and shakers\" data-tweet=\"$FARO $OESX $CERN - Technology movers and shakers https://seekingalpha.com/news/3449413-technology-movers-and-shakers?source=tweet\" data-url=\"https://seekingalpha.com/news/3449413-technology-movers-and-shakers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449405\" data-ts=\"1554833697\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCX\" target=\"_blank\">FCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449405-freeport-sees-no-dividend-hikes-m-while-focusing-on-grasberg-ceo-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Freeport sees no dividend hikes, M&amp;A while focusing on Grasberg, CEO says</a></h4><ul><li>Freeport McMoRan (<a href='https://seekingalpha.com/symbol/FCX' title='Freeport-McMoRan Inc.'>FCX</a> <font color=\"red\">-2.8%</font>) plans <a href=\"https://www.reuters.com/article/chile-mining-freeport-mcmoran/cru-cesco-freeport-plans-no-dividend-hikes-ma-for-2-years-to-focus-on-grasberg-ceo-idUSL1N21R17K\" target=\"_blank\">no dividend raises, acquisitions or debt buybacks</a> over the next two years, CEO Richard Adkerson says at the World Copper Conference in Santiago, Chile.</li><li>Adkerson says FCX wants to focus on expanding its Grasberg copper and gold mine underground for two years, then the company would be \"well situated to then look at further debt reductions, potentially  higher dividends, potential investments in new projects, and we\u2019ll be  open to seeing if there\u2019s anything in the global M&amp;A market that  meets our objectives.\"</li><li>The CEO also dismisses the suggestion by some investors that FCX should be split up, with its Indonesian operations separated from mines in the Americas, citing \"real advantages in our current structure, as we're able to bring the global technological capability of the whole company to bear in Indonesia.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3449405\" data-linked=\"Freeport sees no dividend hikes, M&amp;A while focusing on Grasberg, CEO says\" data-tweet=\"$FCX - Freeport sees no dividend hikes, M&amp;A while focusing on Grasberg, CEO says https://seekingalpha.com/news/3449405-freeport-sees-no-dividend-hikes-m-while-focusing-on-grasberg-ceo-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3449405-freeport-sees-no-dividend-hikes-m-while-focusing-on-grasberg-ceo-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449400\" data-ts=\"1554832939\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449400-amyris-and-rosehill-resources-among-energy-materials-gainers-quintana-energy-services-and-key\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amyris and Rosehill Resources among Energy/Materials gainers; Quintana Energy Services and Key Energy Services losers</a></h4><ul><li><b>Gainers: </b>Amyris (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a>) <font color=\"green\">+12%</font>. Rosehill Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/ROSE' title='Rosehill Resources Inc.'>ROSE</a>) <font color=\"green\">+11%</font>.</li><li><b>Losers: </b>Quintana Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/QES' title='Quintana Energy Services Inc.'>QES</a>) <font color=\"red\">-12%</font>. Key Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a>) <font color=\"red\">-11%</font>. United States Steel (NYSE:<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a>) <font color=\"red\">-9%</font>. Superior Drilling Products (NYSEMKT:<a href='https://seekingalpha.com/symbol/SDPI' title='Superior Drilling Products, Inc.'>SDPI</a>) <font color=\"red\">-7%</font>. Sibanye Gold (NYSE:<a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye Gold Limited'>SBGL</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449400\" data-linked=\"Amyris and Rosehill Resources among Energy/Materials gainers; Quintana Energy Services and Key Energy Services losers\" data-tweet=\"$AMRS $ROSE $QES - Amyris and Rosehill Resources among Energy/Materials gainers; Quintana Energy Services and Key Energy Services losers https://seekingalpha.com/news/3449400-amyris-and-rosehill-resources-among-energy-materials-gainers-quintana-energy-services-and-key?source=tweet\" data-url=\"https://seekingalpha.com/news/3449400-amyris-and-rosehill-resources-among-energy-materials-gainers-quintana-energy-services-and-key\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449390\" data-ts=\"1554829906\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449390-yangtze-river-port-and-logistics-only-financial-gainer-china-internet-nationwide-financial\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yangtze River Port and Logistics the only financial gainer; China Internet Nationwide Financial Services and Grupo Supervielle only losers</a></h4><ul><li><b>Gainers:</b> Yangtze River Port and Logistics (NASDAQ:<a href='https://seekingalpha.com/symbol/YRIV' title='Yangtze River Port and Logistics Limited'>YRIV</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers:</b> China Internet Nationwide Financial Services (NASDAQ:<a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a>) <font color=\"red\">-7%</font>. Grupo Supervielle (NYSE:<a href='https://seekingalpha.com/symbol/SUPV' title='Grupo Supervielle S.A.'>SUPV</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449390\" data-linked=\"Yangtze River Port and Logistics the only financial gainer; China Internet Nationwide Financial Services and Grupo Supervielle only losers\" data-tweet=\"$YRIV $CIFS $SUPV - Yangtze River Port and Logistics the only financial gainer; China Internet Nationwide Financial Services and Grupo Supervielle only losers https://seekingalpha.com/news/3449390-yangtze-river-port-and-logistics-only-financial-gainer-china-internet-nationwide-financial?source=tweet\" data-url=\"https://seekingalpha.com/news/3449390-yangtze-river-port-and-logistics-only-financial-gainer-china-internet-nationwide-financial\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449389\" data-ts=\"1554829889\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449389-under-armourminus-4-after-b-riley-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Under Armour -4% after B. Riley warning</a></h4><ul><li>Shares of Under Armour (<a href='https://seekingalpha.com/symbol/UA' title='Under Armour, Inc.'>UA</a>, <a href='https://seekingalpha.com/symbol/UAA' title='Under Armour, Inc.'>UAA</a>) after B. Riley highlights slowing consumer appreciation as part of a note reiterating a Sell rating.</li><li>The firm says its recent survey showed Under Armour ranking fifth in basketball footwear, sixth in running shoes and seventh in casual footwear. Under Armour stayed in third in apparel behind Nike and Adidas.</li><li>\"This is concerning given footwear is one of Under Armour\u2019s growth vehicles. We believe this is reflective of the limited innovation we have seen in Under Armour footwear compared with Nike and Adidas,\" writes analyst Susan Anderson.</li><li>B. Riley has a price target of $12 on UAA.</li><li>UA <font color=\"red\">-4.00%</font>. UAA <font color=\"red\">-4.42%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449389\" data-linked=\"Under Armour -4% after B. Riley warning\" data-tweet=\"$UA $UAA - Under Armour -4% after B. Riley warning https://seekingalpha.com/news/3449389-under-armourminus-4-after-b-riley-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3449389-under-armourminus-4-after-b-riley-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449386\" data-ts=\"1554829225\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449386-fuel-tech-only-industrial-gainers-pentair-and-hollysys-automation-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fuel Tech only industrial gainers; Pentair and Hollysys Automation among losers</a></h4><ul><li><b>Gainers: </b>Fuel Tech (NASDAQ:<a href='https://seekingalpha.com/symbol/FTEK' title='Fuel Tech, Inc.'>FTEK</a>) <font color=\"green\">+9%</font>.</li><li><b>Losers: </b>Hollysys Automation Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/HOLI' title='Hollysys Automation Technologies Ltd.'>HOLI</a>) <font color=\"red\">-24%</font>. Pentair (NYSE:<a href='https://seekingalpha.com/symbol/PNR' title='Pentair plc'>PNR</a>) <font color=\"red\">-15%</font>. Lindsay (NYSE:<a href='https://seekingalpha.com/symbol/LNN' title='Lindsay Corporation'>LNN</a>) <font color=\"red\">-8%</font>. Attis Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/ATIS' title='Attis Industries, Inc.'>ATIS</a>) <font color=\"red\">-7%</font>. Forterra (NASDAQ:<a href='https://seekingalpha.com/symbol/FRTA' title='Forterra, Inc.'>FRTA</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449386\" data-linked=\"Fuel Tech only industrial gainers; Pentair and Hollysys Automation among losers\" data-tweet=\"$FTEK $HOLI $PNR - Fuel Tech only industrial gainers; Pentair and Hollysys Automation among losers https://seekingalpha.com/news/3449386-fuel-tech-only-industrial-gainers-pentair-and-hollysys-automation-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3449386-fuel-tech-only-industrial-gainers-pentair-and-hollysys-automation-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449382\" data-ts=\"1554828281\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449382-faro-holi-zgnx-and-fixx-among-notable-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FARO, HOLI, ZGNX and FIXX among notable midday movers</a></h4><ul><li><strong>Gainers: </strong>ATA (NASDAQ:<a href='https://seekingalpha.com/symbol/ATAI' title='ATA Inc.'>ATAI</a>) <font color=\"green\">+97%</font>. Provention Bio (NASDAQ:<a href='https://seekingalpha.com/symbol/PRVB' title='Provention Bio, Inc.'>PRVB</a>) <font color=\"green\">+29%</font>. PhaseBio Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/PHAS' title='PhaseBio Pharmaceuticals, Inc.'>PHAS</a>) <font color=\"green\">+24%</font>. Chimerix (NASDAQ:<a href='https://seekingalpha.com/symbol/CMRX' title='Chimerix, Inc.'>CMRX</a>) <font color=\"green\">+22%</font>. FARO Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/FARO' title='FARO Technologies, Inc.'>FARO</a>) <font color=\"green\">+17%</font>. Soliton (NASDAQ:<a href='https://seekingalpha.com/symbol/SOLY' title='Soliton, Inc.'>SOLY</a>) <font color=\"green\">+15%</font>. GEE Group (NYSEMKT:<a href='https://seekingalpha.com/symbol/JOB' title='GEE Group, Inc.'>JOB</a>) <font color=\"green\">+14%</font>. Geron (NASDAQ:<a href='https://seekingalpha.com/symbol/GERN' title='Geron Corporation'>GERN</a>) <font color=\"green\">+12%</font>. Rosehill Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/ROSE' title='Rosehill Resources Inc.'>ROSE</a>) <font color=\"green\">+12%</font>. Netshoes (NYSE:<a href='https://seekingalpha.com/symbol/NETS' title='Netshoes &#40;Cayman&#41; Limited'>NETS</a>) <font color=\"green\">+10%</font>.</li> <li><strong>Losers: </strong>Vaxart (NASDAQ:<a href='https://seekingalpha.com/symbol/VXRT' title='Vaxart, Inc.'>VXRT</a>) <font color=\"red\">-36%</font>. Zosano Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma Corporation'>ZSAN</a>) <font color=\"red\">-24%</font>. Hollysys Automation Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/HOLI' title='Hollysys Automation Technologies Ltd.'>HOLI</a>) <font color=\"red\">-23%</font>. Zogenix (NASDAQ:<a href='https://seekingalpha.com/symbol/ZGNX' title='Zogenix, Inc.'>ZGNX</a>) <font color=\"red\">-23%</font>. Dare Bioscience (NASDAQ:<a href='https://seekingalpha.com/symbol/DARE' title='Daré Bioscience, Inc.'>DARE</a>) <font color=\"red\">-21%</font>. Outlook Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OTLK' title='Outlook Therapeutics, Inc.'>OTLK</a>) <font color=\"red\">-19%</font>.Pentair (NYSE:<a href='https://seekingalpha.com/symbol/PNR' title='Pentair plc'>PNR</a>) <font color=\"red\">-15%</font>. Novartis AG (NYSE:<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a>) <font color=\"red\">-12%</font>.Homology Medicines (NASDAQ:<a href='https://seekingalpha.com/symbol/FIXX' title='Homology Medicines, Inc.'>FIXX</a>) <font color=\"red\">-11%</font>. Niu Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/NIU' title='Niu Technologies'>NIU</a>) <font color=\"red\">-9%</font>.<strong> </strong></li><strong> </strong></ul><div class=\"tiny-share-widget\" data-id=\"3449382\" data-linked=\"FARO, HOLI, ZGNX and FIXX among notable midday movers\" data-tweet=\"$AACG $PRVB $PHAS - FARO, HOLI, ZGNX and FIXX among notable midday movers https://seekingalpha.com/news/3449382-faro-holi-zgnx-and-fixx-among-notable-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3449382-faro-holi-zgnx-and-fixx-among-notable-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449381\" data-ts=\"1554828136\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCG\" target=\"_blank\">PCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449381-pg-and-e-dte-cited-for-failing-to-protect-against-cyber-attacks-wsj\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PG&amp;E, DTE cited for failing to protect against cyber attacks - WSJ</a></h4><ul><li>PG&amp;E (<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a> <font color='red'>-3.5%</font>) and DTE Energy (<a href='https://seekingalpha.com/symbol/DTE' title='DTE Energy Company'>DTE</a> <font color='green'>+0.2%</font>) were among utilities that <a href=\"https://www.wsj.com/articles/pg-e-among-utilities-cited-for-failing-to-protect-against-cyber-and-physical-attacks-11554821337\" target=\"_blank\">broke rules</a> designed to protect the U.S. electric system from cyber and physical attacks and were sanctioned by federal regulators, <em>WSJ</em> reports, citing newly released documents that provided the identities of the violators.</li><li>The identification of the violators follows <a href=\"https://seekingalpha.com/news/3428842-u-s-seeks-10m-fine-duke-energy-violating-cyber-security-rules-wsj\" target=\"_blank\">February reports</a> that Duke Energy broke the same set of rules.</li><li>The cases against and PG&amp;E, DTE and City Utilities of Springfield, Mo., were lodged during 2014-16, a time when U.S. officials say Russia was conducting a major campaign to penetrate utility defenses.</li><li>The newly revealed cases raise questions about the current system designed to encourage self-disclosure from the utilities by keeping the names of violators quiet.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449381\" data-linked=\"PG&amp;E, DTE cited for failing to protect against cyber attacks - WSJ\" data-tweet=\"$PCG $DTE - PG&amp;E, DTE cited for failing to protect against cyber attacks - WSJ https://seekingalpha.com/news/3449381-pg-and-e-dte-cited-for-failing-to-protect-against-cyber-attacks-wsj?source=tweet\" data-url=\"https://seekingalpha.com/news/3449381-pg-and-e-dte-cited-for-failing-to-protect-against-cyber-attacks-wsj\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449378\" data-ts=\"1554827052\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OKTA\" target=\"_blank\">OKTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449378-oktaplus-5-berenberg-sees-new-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Okta +5% as Berenberg sees new upside</a></h4><ul><li>Okta (NASDAQ:<a href='https://seekingalpha.com/symbol/OKTA' title='Okta, Inc.'>OKTA</a>) <font color=\"green\">gains 5%</font> after Berenberg says the company's new advanced server access products are a key growth driver that will open a new market and expand \"the opportunity for every account.\"</li><li>The firm left Okta's recent user conference \"confident that this is only the early phase of large enterprise adoption of the Okta platform.\"</li><li>Rating maintained at Buy with a $92 PT.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3448130-okta-plus-4-percent-analyst-day-praise\" target=\"_blank\">Okta +4% on analyst day praise</a> (April 3)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3448346-okta-gains-new-street-high-target\" target=\"_blank\">Okta gains on new Street-high target</a> (April 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3449378\" data-linked=\"Okta +5% as Berenberg sees new upside\" data-tweet=\"$OKTA - Okta +5% as Berenberg sees new upside https://seekingalpha.com/news/3449378-oktaplus-5-berenberg-sees-new-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3449378-oktaplus-5-berenberg-sees-new-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449375\" data-ts=\"1554826605\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449375-elastic-mongodb-gain-on-google-partnership\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Elastic, MongoDB gain on Google partnership</a></h4><ul><li>Google (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet Inc.'>GOOG</a> <font color='red'>-0.6%</font>)(<a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet Inc.'>GOOGL</a> <font color='red'>-0.5%</font>) Cloud Platform <a href=\"https://techcrunch.com/2019/04/09/google-gives-aws-the-open-source-middle-finger/?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+Techcrunch+%28TechCrunch%29\" target=\"_blank\">adds</a> managed services from new open source partners MongoDB (<a href='https://seekingalpha.com/symbol/MDB' title='MongoDB, Inc.'>MDB</a> <font color='green'>+4.2%</font>), Elastic (<a href='https://seekingalpha.com/symbol/ESTC' title='Elastic N.V.'>ESTC</a> <font color='green'>+2.5%</font>), DataStax, InfluxData, Neo4j, Redis Labs, and Confluent, which <a href=\"https://www.cnbc.com/2019/01/24/microsoft-stake-in-confluent-through-linkedin-gets-more-valuable.html\" target=\"_blank\">counts Microsoft</a> as a stakeholder.</li><li>The move counters rival Amazon's tendency to package open-source projects under its own brand often without giving back to the original project, which caused a scuffle with MongoDB.</li><li>In other news from Google Cloud Next, the company <a href=\"https://techcrunch.com/2019/04/09/google-is-bringing-two-new-data-centers-online-in-2020/?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+Techcrunch+%28TechCrunch%29\" target=\"_blank\">will bring</a> two new data center locations online in 2020: Seoul, South Korea and Salt Lake City, Utah. Google has a total of 15 regions and 45 zones.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449375\" data-linked=\"Elastic, MongoDB gain on Google partnership\" data-tweet=\"$GOOG $GOOGL $MDB - Elastic, MongoDB gain on Google partnership https://seekingalpha.com/news/3449375-elastic-mongodb-gain-on-google-partnership?source=tweet\" data-url=\"https://seekingalpha.com/news/3449375-elastic-mongodb-gain-on-google-partnership\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449370\" data-ts=\"1554825627\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449370-iconix-brand-group-and-new-age-beverages-among-consumer-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Iconix Brand Group and New Age Beverages among consumer losers</a></h4><ul><li><b>Gainers: </b>None</li><li><b>Losers: </b>Niu Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/NIU' title='Niu Technologies'>NIU</a>) <font color=\"red\">-11%</font>. KBS Fashion Group (NASDAQ:<a href='https://seekingalpha.com/symbol/KBSF' title='KBS Fashion Group Limited'>KBSF</a>) <font color=\"red\">-9%</font>. New Age Beverages (NASDAQ:<a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a>) <font color=\"red\">-7%</font>. Iconix Brand Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ICON' title='Iconix Brand Group, Inc.'>ICON</a>) <font color=\"red\">-6%</font>. Superior Industries International (NYSE:<a href='https://seekingalpha.com/symbol/SUP' title='Superior Industries International, Inc.'>SUP</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449370\" data-linked=\"Iconix Brand Group and New Age Beverages among consumer losers\" data-tweet=\"$NIU $KBSF $NBEV - Iconix Brand Group and New Age Beverages among consumer losers https://seekingalpha.com/news/3449370-iconix-brand-group-and-new-age-beverages-among-consumer-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3449370-iconix-brand-group-and-new-age-beverages-among-consumer-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449362\" data-ts=\"1554823920\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNMSF\" target=\"_blank\">SNMSF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449362-spin-master-points-to-strong-upside-on-d-davidson\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spin Master points to strong upside on D.A. Davidson</a></h4><ul> <li>Shares of Spin Master (<a href='https://seekingalpha.com/symbol/SNMSF' title='Spin Master Corp.'>OTC:SNMSF</a>) trades <font color=\"green\">1.5% higher</font> in Toronto after D.A. Davidson launched coverage on the toy seller with a Buy rating.</li> <li>The investment firm thinks Spin Master has high organic growth potential and interesting tech/IP upside.</li> <li>D.A. Davidson's price target of C$51 reps 33% upside potential.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449362\" data-linked=\"Spin Master points to strong upside on D.A. Davidson\" data-tweet=\"$SNMSF - Spin Master points to strong upside on D.A. Davidson https://seekingalpha.com/news/3449362-spin-master-points-to-strong-upside-on-d-davidson?source=tweet\" data-url=\"https://seekingalpha.com/news/3449362-spin-master-points-to-strong-upside-on-d-davidson\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449357\" data-ts=\"1554823335\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WIFI\" target=\"_blank\">WIFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449357-boingo-wireless-deploys-wi-fi-6-john-wayne-airport\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boingo Wireless deploys Wi-Fi 6 at John Wayne Airport</a></h4><ul>   <li>Boingo Wireless (<a href=\"http://seekingalpha.com/symbol/WIFI\" target=\"_blank\">WIFI</a> <font color=\"green\">+3.4%</font>) has <a href=\"https://seekingalpha.com/pr/17470652-boingo-deploys-wi-fi-6-john-wayne-airport\" target=\"_blank\">deployed Wi-Fi 6</a> at John Wayne Airport in Orange County, Calif.</li>    <li>That's the first known deployment of the next-gen wireless networking standard at a major airport, the company believes.</li>    <li>Wi-Fi 6 is based on the 802.11ax standard (with a newer, simpler name).</li>    <li>Boingo deployed its system with Cisco equipment and tested it with Samsung Galaxy phones; the Samsung Galaxy S10 si the first family of smartphones with Wi-Fi 6 support.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449357\" data-linked=\"Boingo Wireless deploys Wi-Fi 6 at John Wayne Airport\" data-tweet=\"$WIFI - Boingo Wireless deploys Wi-Fi 6 at John Wayne Airport https://seekingalpha.com/news/3449357-boingo-wireless-deploys-wi-fi-6-john-wayne-airport?source=tweet\" data-url=\"https://seekingalpha.com/news/3449357-boingo-wireless-deploys-wi-fi-6-john-wayne-airport\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449352\" data-ts=\"1554822189\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449352-cel-sci-and-sellas-life-sciences-among-healthcare-gainers-zogenix-and-dare-bioscience-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CEL-SCI and SELLAS Life Sciences among healthcare gainers; Zogenix and Dare Bioscience among losers</a></h4><ul><li><b>Gainers: </b>PhaseBio Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/PHAS' title='PhaseBio Pharmaceuticals, Inc.'>PHAS</a>) <font color=\"green\">+24%</font>. Chimerix (NASDAQ:<a href='https://seekingalpha.com/symbol/CMRX' title='Chimerix, Inc.'>CMRX</a>) <font color=\"green\">+22%</font>. CEL-SCI (NYSEMKT:<a href='https://seekingalpha.com/symbol/CVM' title='CEL-SCI Corporation'>CVM</a>) <font color=\"green\">+20%</font>. Provention Bio (NASDAQ:<a href='https://seekingalpha.com/symbol/PRVB' title='Provention Bio, Inc.'>PRVB</a>) <font color=\"green\">+18%</font>. SELLAS Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/SLS' title='SELLAS Life Sciences Group, Inc.'>SLS</a>) <font color=\"green\">+11%</font>.</li><li><b>Losers: </b>Vaxart (NASDAQ:<a href='https://seekingalpha.com/symbol/VXRT' title='Vaxart, Inc.'>VXRT</a>) <font color=\"red\">-36%</font>. Zogenix (NASDAQ:<a href='https://seekingalpha.com/symbol/ZGNX' title='Zogenix, Inc.'>ZGNX</a>) <font color=\"red\">-24%</font>. Zosano Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma Corporation'>ZSAN</a>) <font color=\"red\">-24%</font>. Dare Bioscience (NASDAQ:<a href='https://seekingalpha.com/symbol/DARE' title='Daré Bioscience, Inc.'>DARE</a>) <font color=\"red\">-23%</font>. Outlook Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OTLK' title='Outlook Therapeutics, Inc.'>OTLK</a>) <font color=\"red\">-20%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449352\" data-linked=\"CEL-SCI and SELLAS Life Sciences among healthcare gainers; Zogenix and Dare Bioscience among losers\" data-tweet=\"$PHAS $CMRX $CVM - CEL-SCI and SELLAS Life Sciences among healthcare gainers; Zogenix and Dare Bioscience among losers https://seekingalpha.com/news/3449352-cel-sci-and-sellas-life-sciences-among-healthcare-gainers-zogenix-and-dare-bioscience-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3449352-cel-sci-and-sellas-life-sciences-among-healthcare-gainers-zogenix-and-dare-bioscience-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449351\" data-ts=\"1554822103\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLSN\" target=\"_blank\">NLSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449351-nielsen-jumps-3-on-report-sale-come-next-week\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nielsen jumps 3% on report sale could come next week</a></h4><ul>   <li>Nielsen Holdings (NYSE:<a href='https://seekingalpha.com/symbol/NLSN' title='Nielsen Holdings plc'>NLSN</a>) has <font color=\"green\">spiked 3%</font> as StreetInsider reports a long-running sales drama may come to an end <a href=\"https://www.streetinsider.com/Hot+M+and+A/Nielsen+%28NLSN%29+Takeover+Expected+as+Soon+as+Next+Week+-+Source/15354266.html\" target=\"_blank\">as soon as next week</a> with a deal announcement.</li>    <li>CNBC said Friday that Advent International was <a href=\"https://seekingalpha.com/news/3448846-cnbc-advent-goldman-working-nielsen-bid\" target=\"_blank\">teaming up with Goldman Sachs</a> on a bid, and Apollo Global Management was also reportedly working on an offer.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449351\" data-linked=\"Nielsen jumps 3% on report sale could come next week\" data-tweet=\"$NLSN - Nielsen jumps 3% on report sale could come next week https://seekingalpha.com/news/3449351-nielsen-jumps-3-on-report-sale-come-next-week?source=tweet\" data-url=\"https://seekingalpha.com/news/3449351-nielsen-jumps-3-on-report-sale-come-next-week\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449350\" data-ts=\"1554822065\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMBR\" target=\"_blank\">AMBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449350-amber-road-pushes-back-on-altai-nominations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amber Road pushes back on Altai nominations</a></h4><ul><li>Amber Road (NYSE:<a href='https://seekingalpha.com/symbol/AMBR' title='Amber Road, Inc.'>AMBR</a>) stakeholder Altai Capital Management <a href=\"https://seekingalpha.com/pr/17470839-altai-capital-files-definitive-proxy-statement-elect-two-highly-qualified-nominees-amber-road\" target=\"_blank\">nominates</a> two board candidates for potential election at the annual meeting on May 7. Altai cites concerns with AMBR's \"irresponsible handling\" of last year's E2open acquisition proposal and its \"egregious executive compensation.\"</li><li>Amber Road <a href=\"https://seekingalpha.com/pr/17468925-amber-road-inc-files-definitive-proxy-statement-sends-letter-stockholders\" target=\"_blank\">sent out </a>a letter asking shareholders to vote for the company's board candidates.</li><li>AMBR says Altai pressured the company to sell to E2open without fully disclosing Altai's economic interest in the firm.</li><li>Key quote: \"Altai Capital Osprey ... is attempting to derail our progress by electing its own nominees to the Board to pursue Altai's agenda that we believe is misaligned with the interests of the rest of our stockholders.\"</li><li>Amber Road shares are <font color=\"green\">up 1.5%</font> to $8.82.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449350\" data-linked=\"Amber Road pushes back on Altai nominations\" data-tweet=\"$AMBR - Amber Road pushes back on Altai nominations https://seekingalpha.com/news/3449350-amber-road-pushes-back-on-altai-nominations?source=tweet\" data-url=\"https://seekingalpha.com/news/3449350-amber-road-pushes-back-on-altai-nominations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449348\" data-ts=\"1554821143\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449348-lgplus-3-on-apple-shift-to-mini-leds-kuo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LG +3% on Apple shift to mini LEDs - Kuo</a></h4><ul><li>Noted Apple (<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a> <font color='green'>+1%</font>) analyst Ming-Chi Kuo <a href=\"https://www.digitimes.com/news/a20190409PD202.html\" target=\"_blank\">predicts </a>the company will shift to mini LED displays for its computers and tablets over the next two years.</li><li>Mini LED backlighting could appear in the 31.6-inch iMac coming in Q2 or Q3 2019, a 10- to 12-inch iPad coming in Q4 2020 or Q1 2021, and a 15- to 17-inch MacBook in H1 2021.</li><li>The LCD panels will come from LG Display (NYSE:<a href='https://seekingalpha.com/symbol/LPL' title='LG Display Co., Ltd.'>LPL</a>).</li><li>While Apple has moved its phones over to OLED screens, larger OLED displays are cost prohibitive. Mini LEDs offer a thinner panel and better picture quality than traditional LCDs with a lower price tag.</li><li>LPL shares are <font color=\"green\">up 2.9%</font> to $9.43.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449348\" data-linked=\"LG +3% on Apple shift to mini LEDs - Kuo\" data-tweet=\"$AAPL $LPL - LG +3% on Apple shift to mini LEDs - Kuo https://seekingalpha.com/news/3449348-lgplus-3-on-apple-shift-to-mini-leds-kuo?source=tweet\" data-url=\"https://seekingalpha.com/news/3449348-lgplus-3-on-apple-shift-to-mini-leds-kuo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449344\" data-ts=\"1554820963\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SJR\" target=\"_blank\">SJR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449344-shaw-dips-q2-beats-despite-lower-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shaw dips as Q2 beats despite lower revenue</a></h4><ul>   <li>Shaw Communications (<a href=\"http://seekingalpha.com/symbol/SJR\" target=\"_blank\">SJR</a> <font color=\"red\">-2.2%</font>) topped expectations in its Q2 report as it reported postpaid subscriber growth but saw revenues dip year-over-year paced by a drop in Wireless.</li>    <li>Revenues dropped to C$1.32B from C$1.33B, with the drop in Wireless coming to 6.4%, led by a 40% drop in equipment revenue.</li>    <li>The company swung to a net profit of C$155M from a year-ago loss of C$175M.</li>    <li>Free cash flow came to C$160M, vs. a prior-year C$124M.</li>    <li>Wireless postpaid net subscriber additions came to 65,000, bringing the Freedom Mobile customer base to over 1.5M by February's end.</li>    <li>Revenue by segment: Wireline consumer, C$923M (down 0.3%); Wireline business, C$148M (up 5.7%); Wireless Service, C$169M (up 26.1%); Wireless equipment, C$78M (down 40%).</li>    <li>It's on track to meet fiscal 2019 guidance, including consolidated operating income before restructuring costs/amortization up 4-6% Y/Y; capital investments of about C$1.2B; and free cash flow over $500M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3449246-shaw-communications-beats-0_07-beats-revenue\" target=\"_blank\">Shaw Communications beats by $0.07, beats on revenue</a> (Apr. 09 2019)</li>    <li><a href=\"https://seekingalpha.com/pr/17470422-shaw-announces-second-quarter-year-date-fiscal-2019-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3449344\" data-linked=\"Shaw dips as Q2 beats despite lower revenue\" data-tweet=\"$SJR - Shaw dips as Q2 beats despite lower revenue https://seekingalpha.com/news/3449344-shaw-dips-q2-beats-despite-lower-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3449344-shaw-dips-q2-beats-despite-lower-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449343\" data-ts=\"1554820812\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449343-goldman-cuts-pt-on-boeing-says-no-737-max-deliveries-in-q2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman cuts PT on Boeing, says no 737 Max deliveries in Q2</a></h4><ul><li>Shares of the U.S. planemaker are <font color=\"red\">down another 1.1%</font> today as Goldman Sachs became the latest to <a href=\"https://www.businessinsider.sg/boeing-stock-price-target-slashed-goldman-sachs-2019-4/\" target=\"_blank\">lower</a> its PT on Boeing (NYSE:<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a>), which it rates at Neutral.</li><li>\"We revise our 12-month price target to $393 from $425 which reflects the flow through of our reduced estimates, still based on 18.7X CY19E P/E. We have also revised our core 2021-2023 EPS estimates to $25.91/29.43/32.17 from $26.81/29.30/33.47 to reflect changes in the 737 ramp. Key risks: (1) the pace of air traffic growth, (2) 737 MAX reliability, (3) DoD spending priorities.\"</li><li>\"For this year, we assume no MAX deliveries in 2H March and all of 2Q 2019, but that all of those deliveries catch up in 2H19.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3449343\" data-linked=\"Goldman cuts PT on Boeing, says no 737 Max deliveries in Q2\" data-tweet=\"$BA - Goldman cuts PT on Boeing, says no 737 Max deliveries in Q2 https://seekingalpha.com/news/3449343-goldman-cuts-pt-on-boeing-says-no-737-max-deliveries-in-q2?source=tweet\" data-url=\"https://seekingalpha.com/news/3449343-goldman-cuts-pt-on-boeing-says-no-737-max-deliveries-in-q2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449340\" data-ts=\"1554820025\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AJRD\" target=\"_blank\">AJRD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449340-aerojetminus-11-spruce-point-sees-up-to-60-downside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aerojet -11% as Spruce Point sees up to 60% downside</a></h4><ul><li>Aerojet Rocketdyne (NYSE:<a href='https://seekingalpha.com/symbol/AJRD' title='Aerojet Rocketdyne Holdings, Inc.'>AJRD</a>) <font color=\"red\">sinks as much as 11%</font> after Spruce Point Management places a \"Strong Sell\" on shares.</li><li>\"In our opinion, Aerojet Rocketdyne is facing fundamental pressures, masked by complicated and aggressive accounting, which gives investors a potentially misleading impression of stability and growth.\"</li><li>\"While holding no conference calls, and having only four analysts cover the stock, we believe the market is fundamentally ignoring ~$900M of liabilities associated with the business, making the Company 5x more levered than it appears and its valuation 'cheap.'\"</li><li>\"Furthermore, analysts blindly pencil in 4% revenue growth in the next two years, despite hundreds of millions of dollars in revenue programs that are disappearing. We see 40%-60% downside once investors piece the puzzle together.\"</li><li>Check out the full report <a href=\"https://www.sprucepointcap.com/aerojet-rocketdyne-holdings-inc/\" target=\"_blank\">here</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3449340\" data-linked=\"Aerojet -11% as Spruce Point sees up to 60% downside\" data-tweet=\"$AJRD - Aerojet -11% as Spruce Point sees up to 60% downside https://seekingalpha.com/news/3449340-aerojetminus-11-spruce-point-sees-up-to-60-downside?source=tweet\" data-url=\"https://seekingalpha.com/news/3449340-aerojetminus-11-spruce-point-sees-up-to-60-downside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449338\" data-ts=\"1554819981\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APRN\" target=\"_blank\">APRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449338-investors-bid-up-blue-apron-again\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors bid up Blue Apron again</a></h4><ul> <li>Blue Apron (NYSE:<a href='https://seekingalpha.com/symbol/APRN' title='Blue Apron Holdings, Inc.'>APRN</a>) is <font color=\"green\">up 6.15%</font> in morning trading to continue a week-long uptrend in share price since the company <a href=\"https://seekingalpha.com/news/3447907-blue-apron-plus-4-percent-ceo-hiring-reaffirming-guidance\" target=\"_blank\">announced</a> a new CEO and backed its prior guidance.</li> <li>Shares of Blue Apron are now up 16% over the last five sessions.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3449338\" data-linked=\"Investors bid up Blue Apron again\" data-tweet=\"$APRN - Investors bid up Blue Apron again https://seekingalpha.com/news/3449338-investors-bid-up-blue-apron-again?source=tweet\" data-url=\"https://seekingalpha.com/news/3449338-investors-bid-up-blue-apron-again\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449331\" data-ts=\"1554819301\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVYA\" target=\"_blank\">AVYA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449331-cowen-leveraged-buyout-might-make-sense-for-in-transition-avaya\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cowen: Leveraged buyout might make sense for in-transition Avaya</a></h4><ul>   <li>Reports that Avaya Holdings (<a href=\"http://seekingalpha.com/symbol/AVYA\" target=\"_blank\">AVYA</a> <font color=\"green\">+3.4%</font>) is <a href=\"https://seekingalpha.com/news/3449161-avaya-plus-3_9-percent-reports-company-auction-plans\" target=\"_blank\">looking at an auction process</a> after unsolicited interest have Cowen nodding along.</li>    <li>A leveraged buyout \"could make sense, given the company\u2019s top-line transition is not occurring quickly or visibly enough to satisfy public market investors,\" the firm's Lance Vitanza says. He's bullish with a $29 price target (58% upside) based on Avaya staying independent, and notes it's a company with long-term secular pressure on its legacy business and near-term headwinds from a ramping cloud-based business. (h/t Bloomberg)</li>    <li>Avaya is reportedly looking for bids by the end of the month; potential bidders include Apollo Global Management, Permira Holdings and Searchlight Capital Partners.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449331\" data-linked=\"Cowen: Leveraged buyout might make sense for in-transition Avaya\" data-tweet=\"$AVYA - Cowen: Leveraged buyout might make sense for in-transition Avaya https://seekingalpha.com/news/3449331-cowen-leveraged-buyout-might-make-sense-for-in-transition-avaya?source=tweet\" data-url=\"https://seekingalpha.com/news/3449331-cowen-leveraged-buyout-might-make-sense-for-in-transition-avaya\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449327\" data-ts=\"1554818780\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIOS\" target=\"_blank\">BIOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449327-fda-warns-bioscrip-on-sterility-of-drug-products\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA warns BioScrip on sterility of drug products</a></h4><ul><li>The FDA has sent a <a href=\"https://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm635031.htm\" target=\"_blank\">Warning Letter</a> to BioScrip (<a href='https://seekingalpha.com/symbol/BIOS' title='BioScrip, Inc.'>BIOS</a> <font color=\"red\">-3.1%</font>) subsidiary Infusion Partners, LLC concerning deficiencies in its sterile drug product production at its Canfield, OH facility. The letter cites unsanitary conditions that could contaminate products and put patients at risk.</li><li>The company must submit its corrective action plan within 15 working days or face more serious action from the agency.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449327\" data-linked=\"FDA warns BioScrip on sterility of drug products\" data-tweet=\"$BIOS - FDA warns BioScrip on sterility of drug products https://seekingalpha.com/news/3449327-fda-warns-bioscrip-on-sterility-of-drug-products?source=tweet\" data-url=\"https://seekingalpha.com/news/3449327-fda-warns-bioscrip-on-sterility-of-drug-products\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449325\" data-ts=\"1554818609\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449325-sports-directplus-2-after-debenhams-development\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sports Direct +2% after Debenhams development</a></h4><ul> <li>Sports Direct International (<a href='https://seekingalpha.com/symbol/SDIPF' title='Sports Direct International plc'>OTCPK:SDIPF</a>, <a href='https://seekingalpha.com/symbol/SDISY' title='Sports Direct International plc'>OTCPK:SDISY</a>) issues a <a href=\"https://www.sportsdirectplc.com/~/media/files/s/sports-direct/possible-offer-for-debenhams/no%20intention%20to%20bid%20statement%20-%2009042019.pdf\" target=\"_blank\">formal statement</a> indicating that it does not intend to make an offer to acquire Debenhams.</li> <li>The statement follows Debenham's announcement that administrators have been appointed to take control of the retailer.</li> <li>Shares of Sports Direct are <font color=\"green\">up 2.42%</font> in London trading.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3449225-debenhams-close-stores-lenders-grab-control\" target=\"_blank\">Debenhams to close stores as lenders grab control</a> (April 9)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449325\" data-linked=\"Sports Direct +2% after Debenhams development\" data-tweet=\"$SDIPF $SDISY - Sports Direct +2% after Debenhams development https://seekingalpha.com/news/3449325-sports-directplus-2-after-debenhams-development?source=tweet\" data-url=\"https://seekingalpha.com/news/3449325-sports-directplus-2-after-debenhams-development\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449324\" data-ts=\"1554818292\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEUM\" target=\"_blank\">TEUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449324-pareteum-moves-seven-new-customers-production\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pareteum moves seven new customers into production</a></h4><ul>   <li>Pareteum (<a href=\"http://seekingalpha.com/symbol/TEUM\" target=\"_blank\">TEUM</a> <font color=\"red\">-4.3%</font>) launched <a href=\"https://seekingalpha.com/pr/17470199-pareteum-launches-seven-customers-service-production-march\" target=\"_blank\">seven new customers into production</a> during March, it says.</li>    <li>That brings the three-month 2019 total to 15 new customers deployed into commercial service.</li>    <li>The seven new customers include mobile virtual network operators migrating to the Pareteum cloud platform as well as using API interfaces to the platform, along with mobility and security solution providers</li>    <li>The company notes that for the first quarter, it brought 36-month contractual revenue backlog to a total of $938M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449324\" data-linked=\"Pareteum moves seven new customers into production\" data-tweet=\"$TEUM - Pareteum moves seven new customers into production https://seekingalpha.com/news/3449324-pareteum-moves-seven-new-customers-production?source=tweet\" data-url=\"https://seekingalpha.com/news/3449324-pareteum-moves-seven-new-customers-production\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449318\" data-ts=\"1554817762\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OTLK\" target=\"_blank\">OTLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449318-outlook-files-for-downsized-equity-offering-shares-off-11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Outlook files for downsized equity offering; shares off 11%</a></h4><ul><li>Thinly traded nano cap Outlook Therapeutics (<a href='https://seekingalpha.com/symbol/OTLK' title='Outlook Therapeutics, Inc.'>OTLK</a> <font color=\"red\">-10.7%</font>) has filed a <a href=\"https://www.sec.gov/Archives/edgar/data/1649989/000114420419018747/tv517996-s1a.htm\" target=\"_blank\">prospectus </a>for $25M equity offering consisting of ~4.1M shares of common stock, 15-month warrants to purchase up to the same number of shares and five-year warrants to purchase up to the same number of shares.</li><li>Last month, the company <a href=\"https://seekingalpha.com/news/3443938-outlook-therapeutics-files-50m-equity-offering\" target=\"_blank\">filed</a> for a $50M offering of ~7.1M shares.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449318\" data-linked=\"Outlook files for downsized equity offering; shares off 11%\" data-tweet=\"$OTLK - Outlook files for downsized equity offering; shares off 11% https://seekingalpha.com/news/3449318-outlook-files-for-downsized-equity-offering-shares-off-11?source=tweet\" data-url=\"https://seekingalpha.com/news/3449318-outlook-files-for-downsized-equity-offering-shares-off-11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449317\" data-ts=\"1554817663\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LRCX\" target=\"_blank\">LRCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449317-semi-equipments-slip-on-bearish-goldman-note\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Semi equipments slip on bearish Goldman note</a></h4><ul><li>Goldman Sachs analyst Toshiya Hari says the firm is increasingly negative on memory spending and thinks investor expectations for an H2 wafer fab equipment recovery will fade.</li><li>The analyst expects semi equipment companies to revise their WFE forecasts over the next few months and for analysts to cut earnings estimates. Goldman now expects the WFE market to drop 25% Y/Y compared to its previous -20% Y/Y forecast.</li><li>Goldman <a href=\"https://seekingalpha.com/news/3449222-bear-reinstates-kla-tencor\" target=\"_blank\">reinstated KLA</a> at Sell this morning and remains Neutral on Lam Research (<a href='https://seekingalpha.com/symbol/LRCX' title='Lam Research Corporation'>LRCX</a> <font color=\"red\">-1.4%</font>), Applied Materials (<a href='https://seekingalpha.com/symbol/AMAT' title='Applied Materials, Inc.'>AMAT</a> <font color=\"red\">-1.7%</font>), and semi caps broadly.</li><li>Other semi equipment names that could move on the note: IPG Photonics (<a href='https://seekingalpha.com/symbol/IPGP' title='IPG Photonics Corporation'>IPGP</a> <font color=\"red\">-1.5%</font>), Teradyne (<a href='https://seekingalpha.com/symbol/TER' title='Teradyne, Inc.'>TER</a> <font color=\"red\">-0.8%</font>), Cree (<a href='https://seekingalpha.com/symbol/CREE' title='Cree, Inc.'>CREE</a> <font color=\"red\">-1%</font>), Entegris (<a href='https://seekingalpha.com/symbol/ENTG' title='Entegris, Inc.'>ENTG</a> <font color=\"red\">-0.2%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3449317\" data-linked=\"Semi equipments slip on bearish Goldman note\" data-tweet=\"$LRCX $AMAT $LRCX - Semi equipments slip on bearish Goldman note https://seekingalpha.com/news/3449317-semi-equipments-slip-on-bearish-goldman-note?source=tweet\" data-url=\"https://seekingalpha.com/news/3449317-semi-equipments-slip-on-bearish-goldman-note\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449309\" data-ts=\"1554816698\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CERN\" target=\"_blank\">CERN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449309-evercore-steps-up-to-cerner-sideline\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evercore steps up to Cerner sideline</a></h4><ul><li>Evercore ISI upgrades Cerner (NASDAQ:<a href='https://seekingalpha.com/symbol/CERN' title='Cerner Corporation'>CERN</a>) from Underperform to In-line and raises the target from $52 to $64, implying a 12% upside.</li><li>Earlier today, Cerner <a href=\"https://seekingalpha.com/news/3449263-cerner-plus-7-percent-starboard-board-pact\" target=\"_blank\">announced</a> reaching a board pact with activist investor Starboard Value and added $1.2B to its share buyback program.</li><li>Cerner shares are <font color=\"green\">up 11%</font> pre-market to $63.45.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449309\" data-linked=\"Evercore steps up to Cerner sideline\" data-tweet=\"$CERN - Evercore steps up to Cerner sideline https://seekingalpha.com/news/3449309-evercore-steps-up-to-cerner-sideline?source=tweet\" data-url=\"https://seekingalpha.com/news/3449309-evercore-steps-up-to-cerner-sideline\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449307\" data-ts=\"1554816572\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449307-wynn-crown-deal-talks-said-to-be-over\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wynn-Crown deal talks said to be over</a></h4><ul> <li>Wynn Resorts (NASDAQ:<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a>) has <a href=\"https://www.cnbc.com/2019/04/09/wynn-terminating-discussions-with-australias-crown-resorts-after-deal-talks-leaked.html\" target=\"_blank\">cut off</a> all talks with Crown Resorts (<a href='https://seekingalpha.com/symbol/CWLDF' title='Crown Resorts Ltd.'>OTCPK:CWLDF</a>) about a merger after the deal talks leaked to the media, according to CNBC.</li> <li>Shares of Wynn are <font color=\"red\">down 1.0%</font> in premarket trading.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3449183-wynn-resorts-makes-7_1b-offer-australia-s-crown-resorts\" target=\"_blank\">Wynn Resorts makes $7.1B offer for Australia\u2019s Crown Resorts</a> (April 8)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3449214-wynn-resorts-seen-playing-defense-crown-pursuit\" target=\"_blank\">Wynn Resorts seen playing defense with Crown pursuit</a> (April 9)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3449307\" data-linked=\"Wynn-Crown deal talks said to be over\" data-tweet=\"$WYNN $CWLDF - Wynn-Crown deal talks said to be over https://seekingalpha.com/news/3449307-wynn-crown-deal-talks-said-to-be-over?source=tweet\" data-url=\"https://seekingalpha.com/news/3449307-wynn-crown-deal-talks-said-to-be-over\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449301\" data-ts=\"1554815918\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZSAN\" target=\"_blank\">ZSAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449301-zosano-down-26-on-pricing-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zosano down 26% on pricing equity offering</a></h4><ul> <li>Zosano Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma Corporation'>ZSAN</a>) <a href=\"https://seekingalpha.com/pr/17470793-zosano-announces-pricing-public-offering-common-stock\" target=\"_blank\">prices</a> public offering of common stock for gross proceeds of $17.5M.</li><li>Underwriters over-allotment is $2.625M additional shares.</li>     <li>Net proceeds will be used for development and commercialization of Qtrypta (M207), and for working capital and general corporate purposes.</li><li>Closing date is April 11.</li><li>Shares are down <font color=\"red\">26%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3449128-zosano-18-percent-hours-equity-offering\" target=\"_blank\">Zosano down 18% after hours on equity offering</a> (April 8)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3449301\" data-linked=\"Zosano down 26% on pricing equity offering\" data-tweet=\"$ZSAN - Zosano down 26% on pricing equity offering https://seekingalpha.com/news/3449301-zosano-down-26-on-pricing-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3449301-zosano-down-26-on-pricing-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449300\" data-ts=\"1554815908\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTCT\" target=\"_blank\">NTCT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449300-netscoutminus-3_4-on-preliminary-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NetScout -3.4% on preliminary Q4 results</a></h4><ul><li>NetScout (NASDAQ:<a href='https://seekingalpha.com/symbol/NTCT' title='NetScout Systems, Inc.'>NTCT</a>) <a href=\"https://seekingalpha.com/pr/17470666-netscout-systems-reports-preliminary-financial-results-fourth-quarter-full-fiscal-year-2019\" target=\"_blank\">reports </a>preliminary Q4 revenue of $235M, about $15M below expectations and missing the $249.2M consensus. The reduction was primarily due to delayed revenue recognition on a large project for a mobile operator.</li><li>The company expects the revenue to be recognized over the next several quarters.</li><li>Q4 EPS straddles consensus with $0.59 to $0.64 compared to the $0.61 estimate.</li><li>NTCT shares are <font color=\"red\">down 3.4% </font>pre-market to $27.41.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449300\" data-linked=\"NetScout -3.4% on preliminary Q4 results\" data-tweet=\"$NTCT - NetScout -3.4% on preliminary Q4 results https://seekingalpha.com/news/3449300-netscoutminus-3_4-on-preliminary-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3449300-netscoutminus-3_4-on-preliminary-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449296\" data-ts=\"1554815664\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RARX\" target=\"_blank\">RARX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449296-ra-pharma-finalizing-design-of-phase-3-zilucoplan-study-in-myasthenia-gravis-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ra Pharma finalizing design of Phase 3 zilucoplan study in myasthenia gravis; shares up 2% premarket</a></h4><ul><li>Ra Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/RARX' title='Ra Pharmaceuticals, Inc.'>RARX</a>) is up <font color=\"green\">2%</font> premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17470176-ra-pharmaceuticals-announces-completion-end-phase-2-interactions-fda-design-pivotal-phase-3\" target=\"_blank\">announcement </a>that it has completed its End-of-Phase 2 interactions with the FDA and is putting the finishing touches on a pivotal Phase 3 study evaluating zilucoplan in patients with <a href=\"https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Myasthenia-Gravis-Fact-Sheet\" target=\"_blank\">generalized myasthenia gravis</a> (gMG), an autoimmune disorder characterized by weakness in the skeletal muscles.</li><li>The trial, expected to launch in H2, will assess a once-daily self-administered subcutaneous dose of 0.3 mg/kg of zilucoplan compared to placebo in ~130 gMG subjects who are acetylcholine receptor antibody-positive, regardless of prior treatments.</li><li>The primary endpoint will be the change in a scale called MG-ADL from baseline to week 12. After the trial ends, participants will have the option to enroll in an open-label long-term extension study.</li><li>Ra says zilucoplan is a synthetic macrocyclic peptide that binds to complement component 5 (C5), inhibiting its cleavage into C5a and C5b. It is designed to disrupt the interaction between C5b and C6 and prevent assembly of the membrane attack complex which causes the breakdown of red blood cells.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449296\" data-linked=\"Ra Pharma finalizing design of Phase 3 zilucoplan study in myasthenia gravis; shares up 2% premarket\" data-tweet=\"$RARX - Ra Pharma finalizing design of Phase 3 zilucoplan study in myasthenia gravis; shares up 2% premarket https://seekingalpha.com/news/3449296-ra-pharma-finalizing-design-of-phase-3-zilucoplan-study-in-myasthenia-gravis-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3449296-ra-pharma-finalizing-design-of-phase-3-zilucoplan-study-in-myasthenia-gravis-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449294\" data-ts=\"1554815609\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449294-healthcare-stocks-among-major-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare stocks among major premarket losers</a></h4><ul><li>Vaxart (NASDAQ:<a href='https://seekingalpha.com/symbol/VXRT' title='Vaxart, Inc.'>VXRT</a>) <font color=\"red\">-37%</font> on <a href=\"https://seekingalpha.com/news/3449203-vaxart-35-percent-pricing-equity-offering\" target=\"_blank\">pricing</a> stock offering.</li><li>Zogenix (NASDAQ:<a href='https://seekingalpha.com/symbol/ZGNX' title='Zogenix, Inc.'>ZGNX</a>) <font color=\"red\">-28%</font> after FDA <a href=\"https://seekingalpha.com/news/3449121-fda-rejects-zogenix-application-dravet-med-fintepla\" target=\"_blank\">rejects</a> application for Dravet med Fintepla.</li><li>Zosano Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma Corporation'>ZSAN</a>) <font color=\"red\">-27%</font> on <a href=\"https://seekingalpha.com/news/3449128-zosano-18-percent-hours-equity-offering\" target=\"_blank\">announcing</a> equity offering.</li><li>Dare Bioscience (NASDAQ:<a href='https://seekingalpha.com/symbol/DARE' title='Daré Bioscience, Inc.'>DARE</a>) <font color=\"red\">-26%</font> on <a href=\"https://seekingalpha.com/news/3449277-dare-bio-23-percent-pricing-stock-offering\" target=\"_blank\">pricing</a> stock offering.</li><li>Novartis AG (NYSE:<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a>) <font color=\"red\">-11%</font> on <a href=\"https://seekingalpha.com/news/3449205-novartis-completes-alcon-spin\" target=\"_blank\">completing</a> Alcon spin-off.</li><li>Shineco (NASDAQ:<a href='https://seekingalpha.com/symbol/TYHT' title='Shineco, Inc.'>TYHT</a>) <font color=\"red\">-6%</font>.</li><li>New Age Beverages (NASDAQ:<a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a>) <font color=\"red\">-6%</font> after yesterday's pop following <a href=\"https://seekingalpha.com/news/3449281-new-age-beverages-cools-39-percent-pop\" target=\"_blank\">news</a> of an expanded Marley deal with Walmart.</li><li>Aerojet Rocketdyne Holdings (NYSE:<a href='https://seekingalpha.com/symbol/AJRD' title='Aerojet Rocketdyne Holdings, Inc.'>AJRD</a>) <font color=\"red\">-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449294\" data-linked=\"Healthcare stocks among major premarket losers\" data-tweet=\"$VXRT $ZGNX $ZSAN - Healthcare stocks among major premarket losers https://seekingalpha.com/news/3449294-healthcare-stocks-among-major-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3449294-healthcare-stocks-among-major-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449292\" data-ts=\"1554815417\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449292-cern-scyx-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CERN, SCYX among premarket gainers</a></h4><ul><li>PhaseBio Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/PHAS' title='PhaseBio Pharmaceuticals, Inc.'>PHAS</a>) <font color=\"green\">+25%</font> on <a href=\"https://seekingalpha.com/news/3449268-phasebio-licenses-sarcopenia-candidate-pb1023\" target=\"_blank\">out-licenses</a> sarcopenia candidate PB1023.</li><li>Cerner (NASDAQ:<a href='https://seekingalpha.com/symbol/CERN' title='Cerner Corporation'>CERN</a>) <font color=\"green\">+10%</font> on Starboard board <a href=\"https://seekingalpha.com/news/3449263-cerner-plus-7-percent-starboard-board-pact\" target=\"_blank\">pact</a>.</li><li>SCYNEXIS (NASDAQ:<a href='https://seekingalpha.com/symbol/SCYX' title='SCYNEXIS, Inc.'>SCYX</a>) <font color=\"green\">+7%</font>.</li><li>ATA (NASDAQ:<a href='https://seekingalpha.com/symbol/ATAI' title='ATA Inc.'>ATAI</a>) <font color=\"green\">+7%</font> on <a href=\"https://seekingalpha.com/pr/17470549-ata-announces-entry-preliminary-agreements-acquisition-leading-chinese-service-provider\" target=\"_blank\">entering</a> into preliminary agreements for acquisition of a leading Chinese service provider of overseas art education.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449292\" data-linked=\"CERN, SCYX among premarket gainers\" data-tweet=\"$PHAS $CERN $SCYX - CERN, SCYX among premarket gainers https://seekingalpha.com/news/3449292-cern-scyx-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3449292-cern-scyx-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449285\" data-ts=\"1554814955\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLDP\" target=\"_blank\">BLDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449285-ballard-power-wins-fuel-cell-module-supply-deal-for-norway-ferry\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ballard Power wins fuel cell module supply deal for Norway ferry</a></h4><ul><li>Ballard Power Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/BLDP' title='Ballard Power Systems Inc.'>BLDP</a>) <font color=\"green\">+3.1%</font> pre-market after saying it signed a deal to <a href=\"https://seekingalpha.com/pr/17470023-ballard-signs-supply-agreement-norled-fuel-cell-modules-power-ferry-norway\" target=\"_blank\">provide fuel cell modules</a> for Norwegian ferry operator Norled; financial terms are not disclosed.</li><li>Under the agreement, BLDP will provide two 200 KW modules that will be used to power a hybrid ferry planned to begin operating in 2021.</li><li>BLDP says the Norled vessel would be the first liquid hydrogen fuel cell-powered ferry in commercial operation globally.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449285\" data-linked=\"Ballard Power wins fuel cell module supply deal for Norway ferry\" data-tweet=\"$BLDP - Ballard Power wins fuel cell module supply deal for Norway ferry https://seekingalpha.com/news/3449285-ballard-power-wins-fuel-cell-module-supply-deal-for-norway-ferry?source=tweet\" data-url=\"https://seekingalpha.com/news/3449285-ballard-power-wins-fuel-cell-module-supply-deal-for-norway-ferry\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449281\" data-ts=\"1554814863\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBEV\" target=\"_blank\">NBEV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449281-new-age-beverages-cools-off-after-39-pop\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Age Beverages cools off after 39% pop</a></h4><ul> <li>New Age Beverages (NASDAQ:<a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a>) is <font color=\"red\">down 4.85%</font> in premarket trading after yesterday's pop following <a href=\"https://seekingalpha.com/news/3449080-new-age-beverages-24-percent-expanded-walmart-deal\" target=\"_blank\">news</a> of an expanded Marley deal with Walmart.</li> <li>The company says it plans to run \"hyper-targeted GeoFraming campaigns\" to drive foot traffic to Walmart stores on its view that there is a \"significant\" opportunity to gain Marley brand recognition with consumers.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3449281\" data-linked=\"New Age Beverages cools off after 39% pop\" data-tweet=\"$NBEV - New Age Beverages cools off after 39% pop https://seekingalpha.com/news/3449281-new-age-beverages-cools-off-after-39-pop?source=tweet\" data-url=\"https://seekingalpha.com/news/3449281-new-age-beverages-cools-off-after-39-pop\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449278\" data-ts=\"1554814365\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAL\" target=\"_blank\">AAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449278-american-pulls-back-on-q1-unit-revenue-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American pulls back on Q1 unit revenue guidance</a></h4><ul> <li>American Airlines (NASDAQ:<a href='https://seekingalpha.com/symbol/AAL' title='American Airlines Group Inc.'>AAL</a>) dips slightly after updating guidance for Q1.</li> <li>The company says Q1 capacity was slightly higher than previous guidance due to a better completion factor offset in part by flight cancellations.</li> <li>Q1 cost per available seat mile is expected to be up 3.0% Y/Y.</li> <li>Q1 total revenue per available seat mile is anticipated to be approximately flat to up 1.0% Y/Y vs. prior guidance of flat to up 2.0%. The lowered unit revenue guidance is due primarily to the impact of the government shutdown, the grounding of the company's MAX fleet and the removal from service of the 14 737-800 aircraft.</li> <li><a href=\"https://seekingalpha.com/filing/4439336\" target=\"_blank\">SEC Form 8-K</a></li> <li>AAL <font color=\"red\">-0.44%</font> premarket to $33.73.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449278\" data-linked=\"American pulls back on Q1 unit revenue guidance\" data-tweet=\"$AAL - American pulls back on Q1 unit revenue guidance https://seekingalpha.com/news/3449278-american-pulls-back-on-q1-unit-revenue-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3449278-american-pulls-back-on-q1-unit-revenue-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449277\" data-ts=\"1554814314\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DARE\" target=\"_blank\">DARE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449277-dar-bio-down-23-on-pricing-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Daré Bio down 23% on pricing stock offering</a></h4><ul> <li>Daré Bioscience (NASDAQ:<a href='https://seekingalpha.com/symbol/DARE' title='Daré Bioscience, Inc.'>DARE</a>) <a href=\"https://seekingalpha.com/pr/17470610-dare-bioscience-inc-prices-underwritten-public-offering-common-stock\" target=\"_blank\">prices</a> its public offering of 4,575,000 common shares at $1.10 per share.</li><li>Underwriters over-allotment is an additional 686,250 shares.</li><li>Net proceeds of ~$4.4M will be used for working capital and general corporate purposes.</li><li>Closing date is April 11.</li><li>Shares are down <font color=\"red\">23%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3449143-dare-bio-launches-equity-offering-shares-19-percent-hours\" target=\"_blank\">Daré Bio launches equity offering; shares down 19% after hours</a> (April 8)</li>         </ul><div class=\"tiny-share-widget\" data-id=\"3449277\" data-linked=\"Daré Bio down 23% on pricing stock offering\" data-tweet=\"$DARE - Daré Bio down 23% on pricing stock offering https://seekingalpha.com/news/3449277-dar-bio-down-23-on-pricing-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3449277-dar-bio-down-23-on-pricing-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449271\" data-ts=\"1554813675\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CEMI\" target=\"_blank\">CEMI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449271-chembios-zika-dengue-and-chikungunya-multiplex-test-approved-in-brazil\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chembio&#39;s zika, dengue and chikungunya multiplex test approved in Brazil</a></h4><ul> <li>Agência Nacional de Vigilância Sanitária ((ANVISA)), Brazil\u2019s health regulatory agency <a href=\"https://seekingalpha.com/pr/17470390-chembio-diagnostics-announces-approval-zika-dengue-chikungunya-point-care-multiplex-test\" target=\"_blank\">approves</a> Chembio Diagnostics' (NASDAQ:<a href='https://seekingalpha.com/symbol/CEMI' title='Chembio Diagnostics, Inc.'>CEMI</a>) DPP Zika/Dengue/Chikungunya System.</li>   <li>Chembio\u2019s DPP Zika/Dengue/Chikungunya multiplex test allows simultaneous and discrete detection of antibodies for both active (IgM) and prior exposure (IgG) to the Zika, dengue, and chikungunya viruses, which is important for both treatment and surveillance.</li><li>Shares are up <font color=\"green\">3%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3449271\" data-linked=\"Chembio&#39;s zika, dengue and chikungunya multiplex test approved in Brazil\" data-tweet=\"$CEMI - Chembio&#39;s zika, dengue and chikungunya multiplex test approved in Brazil https://seekingalpha.com/news/3449271-chembios-zika-dengue-and-chikungunya-multiplex-test-approved-in-brazil?source=tweet\" data-url=\"https://seekingalpha.com/news/3449271-chembios-zika-dengue-and-chikungunya-multiplex-test-approved-in-brazil\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449268\" data-ts=\"1554813421\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PHAS\" target=\"_blank\">PHAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449268-phasebio-out-licenses-sarcopenia-candidate-pb1023\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PhaseBio out-licenses sarcopenia candidate PB1023</a></h4><ul><li>PhaseBio (NASDAQ:<a href='https://seekingalpha.com/symbol/PHAS' title='PhaseBio Pharmaceuticals, Inc.'>PHAS</a>) <a href=\"https://seekingalpha.com/pr/17470400-phasebio-announces-global-license-pb1023-treatment-sarcopenia-related-diseases-immunoforge\" target=\"_blank\">licenses </a>pipeline candidate PB1023, a long-acting recombinant GLP-1 analogue, to ImmunoForge for the treatment of certain diseases, including conditions associated with sarcopenia (age-related muscle loss).</li><li>Under the terms of the exclusive global license, PHAS will receive an upfront payment, milestones and sales-based royalties, including sales from sublicense agreements. Specific financial terms remain confidential.</li><li>Shares are up <font color=\"green\">24%</font> premarket on increased volume in response to Breakthrough Therapy status for Brilinta reversal agent PB2452 <a href=\"https://seekingalpha.com/news/3449132-phasebio-nabs-accelerated-review-status-u-s-pb2452-shares-17-percent-hours\" target=\"_blank\">announced </a>yesterday after the close.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449268\" data-linked=\"PhaseBio out-licenses sarcopenia candidate PB1023\" data-tweet=\"$PHAS - PhaseBio out-licenses sarcopenia candidate PB1023 https://seekingalpha.com/news/3449268-phasebio-out-licenses-sarcopenia-candidate-pb1023?source=tweet\" data-url=\"https://seekingalpha.com/news/3449268-phasebio-out-licenses-sarcopenia-candidate-pb1023\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449265\" data-ts=\"1554813052\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DIS\" target=\"_blank\">DIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449265-disney-gets-boost-from-cowen-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Disney gets boost from Cowen upgrade</a></h4><ul><li>Bullish on Star Wars and its streaming service launch, Cowen has <a href=\"https://www.cnbc.com/2019/04/09/calls-of-the-day-disney-more.html\" target=\"_blank\">upgraded</a> Disney (NYSE:<a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a>) to Outperform from Market Perform and upped its PT to $131 from $102.</li><li>\"We view Disney's catalyst path for the next year as highly attractive, and believe Thursday\u2019s investor day will likely be a deck-clearing event for sentiment. Note, however, that we continue to have longer-term concerns about the the Fox acquisition and the ability of DTC video to improve deteriorating content aggregation economics.\"</li><li>DIS <font color=\"green\">+0.8%</font> premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3449265\" data-linked=\"Disney gets boost from Cowen upgrade\" data-tweet=\"$DIS - Disney gets boost from Cowen upgrade https://seekingalpha.com/news/3449265-disney-gets-boost-from-cowen-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3449265-disney-gets-boost-from-cowen-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449263\" data-ts=\"1554812765\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CERN\" target=\"_blank\">CERN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449263-cernerplus-7-on-starboard-board-pact\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cerner +7% on Starboard board pact</a></h4><ul><li>Cerner (NASDAQ:<a href='https://seekingalpha.com/symbol/CERN' title='Cerner Corporation'>CERN</a>) <a href=\"https://seekingalpha.com/pr/17470276-cerner-announces-agreement-starboard-value-regarding-board-refreshment-operational\" target=\"_blank\">reaches a pact</a> with activist investor Starboard Value and appoints four new directors to the board.</li><li>Starboard, which owns about 1.2% of CERN, agrees to vote in favor of the nominees.</li><li>Cerner also boosts its share buyback program by $1.2B, making about $1.5B available in total.</li><li>The company hired outside consulting firm AlixPartners to review its operations and cost structure.</li><li>CERN shares are <font color=\"green\">up 7.3%</font> pre-market to $61.25.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449263\" data-linked=\"Cerner +7% on Starboard board pact\" data-tweet=\"$CERN - Cerner +7% on Starboard board pact https://seekingalpha.com/news/3449263-cernerplus-7-on-starboard-board-pact?source=tweet\" data-url=\"https://seekingalpha.com/news/3449263-cernerplus-7-on-starboard-board-pact\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449262\" data-ts=\"1554812739\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VBIV\" target=\"_blank\">VBIV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449262-vbi-vaccines-up-7-premarket-ahead-of-sci-b-vac-presentation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VBI Vaccines up 7% premarket ahead of Sci-B-Vac presentation</a></h4><ul><li>VBI Vaccines (NASDAQ:<a href='https://seekingalpha.com/symbol/VBIV' title='VBI Vaccines Inc.'>VBIV</a>) is up <font color=\"green\">7%</font> premarket on light volume ahead of a <a href=\"https://seekingalpha.com/pr/17470421-vbi-vaccines-announces-late-breaking-poster-presentation-easl-2019\" target=\"_blank\">presentation </a>at EASL in Vienna on hepatitis B vaccine Sci-B-Vac later this week.</li><li>Chief Medical Officer Francisco Diaz-Mitoma, M.D., Ph.D. will present safety and immunogenicity data from three previous studies, two Phase 3s comparing Sci-B-Vac to GlaxoSmithKline's (NYSE:<a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline plc'>GSK</a>) <a href=\"https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Engerix-B/pdf/ENGERIX-B.PDF\" target=\"_blank\">Engerix-B</a> and a single-arm Phase 4 conducted in Israel. All showed seroprotection rates greater than 98% after two vaccinations with a favorable safety profile.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449262\" data-linked=\"VBI Vaccines up 7% premarket ahead of Sci-B-Vac presentation\" data-tweet=\"$VBIV $GSK - VBI Vaccines up 7% premarket ahead of Sci-B-Vac presentation https://seekingalpha.com/news/3449262-vbi-vaccines-up-7-premarket-ahead-of-sci-b-vac-presentation?source=tweet\" data-url=\"https://seekingalpha.com/news/3449262-vbi-vaccines-up-7-premarket-ahead-of-sci-b-vac-presentation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449257\" data-ts=\"1554812339\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWLO\" target=\"_blank\">TWLO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449257-twilio-gains-on-new-bull-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twilio gains on new bull (update)</a></h4><ul><li>FBN Securities initiates Twilio (NYSE:<a href='https://seekingalpha.com/symbol/TWLO' title='Twilio Inc.'>TWLO</a>) at Outperform with a PT of $150, implying a 23% upside.</li><li>Twilio is expected to report earnings on May 14. Analysts <a href=\"https://seekingalpha.com/symbol/TWLO/earnings\" target=\"_blank\">estimate</a> revenue of $223.64M with $0.01 EPS.</li><li>Twilio shares are <font color=\"green\">up 0.4%</font> pre-market to $122.66.</li><li>Update with details from the analyst note:</li><li>FBN's Shebly Seyrafi expects \"robust\" sales growth due to rising ARPU and \"stable active customer growth.\"</li><li>The analyst expects 65% revenue growth in 2019 and notes that Twilio exceeded revenue consensus by 11% to 13% in each quarter of FY18.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449257\" data-linked=\"Twilio gains on new bull (update)\" data-tweet=\"$TWLO - Twilio gains on new bull (update) https://seekingalpha.com/news/3449257-twilio-gains-on-new-bull-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3449257-twilio-gains-on-new-bull-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449245\" data-ts=\"1554811272\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBRX\" target=\"_blank\">MBRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449245-moleculinplus-11-on-expanding-leukemia-drug-program\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Moleculin +11% on expanding leukemia drug program</a></h4><ul> <li>Moleculin Biotech (NASDAQ:<a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a>) has successfully <a href=\"https://seekingalpha.com/pr/17470250-moleculin-announces-successful-expansion-leukemia-drug-program\" target=\"_blank\">expanded</a> the clinical supply of Annamycin for its on-going clinical trials via BSP Pharmaceuticals S.p.A. in Latina, Italy.</li><li>Annamycin is a member of the anthracycline class of chemotherapeutic agents (includes doxorubicin).</li><li>Shares are up <font color=\"green\">11%</font> premarket.</li>                   </ul><div class=\"tiny-share-widget\" data-id=\"3449245\" data-linked=\"Moleculin +11% on expanding leukemia drug program\" data-tweet=\"$MBRX - Moleculin +11% on expanding leukemia drug program https://seekingalpha.com/news/3449245-moleculinplus-11-on-expanding-leukemia-drug-program?source=tweet\" data-url=\"https://seekingalpha.com/news/3449245-moleculinplus-11-on-expanding-leukemia-drug-program\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449243\" data-ts=\"1554811047\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LNN\" target=\"_blank\">LNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449243-lindsayminus-11-flooding-impacts-unknown\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lindsay -11 as flooding impacts &#39;unknown&#39;</a></h4><ul><li>Adjusted net earnings for FQ2 were $0.2M, or $0.02 per diluted share.</li><li>Irrigation equipment revenues -14% to $95.8M from the same quarter a year ago. International irrigation revenues +15% to $38.1M. Infrastructure segment revenues -27% to $13.4M.</li><li>Backlog of unshipped orders at February 28, 2019 was $44.4M vs. $90.2M in the prior year.</li><li>Outlook: \"Impacts of the recent widespread flooding in the Midwest are unknown at this time, and we don\u2019t expect to see meaningful improvement in farmer sentiment while the U.S-China trade uncertainty persists,\" said CEO Tim Hassinger.</li><li><a href='https://seekingalpha.com/symbol/LNN' title='Lindsay Corporation'>LNN</a> <font color=\"red\">-11%</font> premarket</li><li><a href=\"https://seekingalpha.com/news/3449206-lindsay-eps-0_02\" target=\"_blank\">FQ2 results</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3449243\" data-linked=\"Lindsay -11 as flooding impacts &#39;unknown&#39;\" data-tweet=\"$LNN - Lindsay -11 as flooding impacts &#39;unknown&#39; https://seekingalpha.com/news/3449243-lindsayminus-11-flooding-impacts-unknown?source=tweet\" data-url=\"https://seekingalpha.com/news/3449243-lindsayminus-11-flooding-impacts-unknown\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449240\" data-ts=\"1554810954\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZS\" target=\"_blank\">ZS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449240-zscalerplus-2_4-on-new-street-high-target-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zscaler +2.4% on new Street-high target (update)</a></h4><ul><li>Credit Suisse raises its Zscaler (NASDAQ:<a href='https://seekingalpha.com/symbol/ZS' title='Zscaler, Inc.'>ZS</a>) target from $55 to the Street-high $75 citing growing conviction in the long-term growth with no real competition.</li><li>Rating maintained at Outperform.</li><li>ZS shares are <font color=\"green\">up 2.4%</font> pre-market to $65.</li><li>Update with more details from the analyst note:</li><li>Analyst Brad Zelnick says seeing \"incumbent vendors virtualize on-premise hardware to run in the Cloud helps validate ZS\u2019s solution,\" and those rivals lack Zscaler's innate scale, flexibility, and performance.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449240\" data-linked=\"Zscaler +2.4% on new Street-high target (update)\" data-tweet=\"$ZS - Zscaler +2.4% on new Street-high target (update) https://seekingalpha.com/news/3449240-zscalerplus-2_4-on-new-street-high-target-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3449240-zscalerplus-2_4-on-new-street-high-target-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449237\" data-ts=\"1554810671\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAP\" target=\"_blank\">SAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449237-sapminus-2_3-on-two-downgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SAP -2.3% on two downgrades</a></h4><ul><li>HSBC downgrades SAP (NYSE:<a href='https://seekingalpha.com/symbol/SAP' title='SAP SE'>SAP</a>) from Buy to Hold seeing a less favorable risk/reward balance.</li><li>UBS drops SAP from Buy to Neutral on \"limited upside potential\" with no inflection in S/4 adoption this year. The firm expects an in-line Q1 report and says SAP's 2020 goal of 71% gross margin still seems \"unattainable.\"</li><li>SAP is expected to report earnings on April 24. Analysts <a href=\"https://seekingalpha.com/symbol/SAP/earnings\" target=\"_blank\">estimate</a> $6.67B in revenue with $0.96 EPS.</li><li>SAP shares are <font color=\"red\">down 2.3%</font> pre-market to $112.34.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449237\" data-linked=\"SAP -2.3% on two downgrades\" data-tweet=\"$SAP - SAP -2.3% on two downgrades https://seekingalpha.com/news/3449237-sapminus-2_3-on-two-downgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3449237-sapminus-2_3-on-two-downgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449234\" data-ts=\"1554810383\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMRX\" target=\"_blank\">CMRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449234-chimerix-beefs-up-management-team-shares-up-13-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chimerix beefs up management team; shares up 13% premarket</a></h4><ul><li>Chimerix (NASDAQ:<a href='https://seekingalpha.com/symbol/CMRX' title='Chimerix, Inc.'>CMRX</a>) <a href=\"https://seekingalpha.com/pr/17469881-chimerix-announces-management-updates\" target=\"_blank\">announces</a> following appointments:</li><li>Michael A. Sherman, former CEO of Endocyte, appointed as CEO of Chimerix, effective immediately.</li><li>Michael T. Andriole, former CFO of Endocyte, appointed to the newly created position of Chief Business Officer.</li><li>Shares are up <font color=\"green\">13%</font> premarket.</li>         </ul><div class=\"tiny-share-widget\" data-id=\"3449234\" data-linked=\"Chimerix beefs up management team; shares up 13% premarket\" data-tweet=\"$CMRX - Chimerix beefs up management team; shares up 13% premarket https://seekingalpha.com/news/3449234-chimerix-beefs-up-management-team-shares-up-13-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3449234-chimerix-beefs-up-management-team-shares-up-13-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449233\" data-ts=\"1554810107\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MUX\" target=\"_blank\">MUX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449233-mcewen-mining-reports-q1-output-explores-sale-of-mexican-assets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">McEwen Mining reports Q1 output, explores sale of Mexican assets</a></h4><ul><li>McEwen Mining (NYSE:<a href='https://seekingalpha.com/symbol/MUX' title='McEwen Mining Inc.'>MUX</a>) <font color=\"green\">+1.8%</font> pre-market after reporting <a href=\"https://seekingalpha.com/pr/17470109-mcewen-mining-reports-q1-2019-production-results\" target=\"_blank\">Q1 production results</a> and saying it is exploring the potential sale of its Mexican assets.</li><li>MUX says half of net proceeds from a potential sale would be used to advance development projects, with the rest used to pay down debt.</li><li>The company reports Q1 gold production fell 23% Y/Y to 26,789 oz. and silver output rose 10% to 703,217 oz., with gold equiv. production declining 18% to 36,166 oz.</li><li>Chairman Rob McEwen says gold production \"improved significantly\" at the Black Fox mine in March, and \"the issues that  pushed the start-up of commercial production at Gold Bar from Q1 into Q2  have largely been resolved.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3449233\" data-linked=\"McEwen Mining reports Q1 output, explores sale of Mexican assets\" data-tweet=\"$MUX - McEwen Mining reports Q1 output, explores sale of Mexican assets https://seekingalpha.com/news/3449233-mcewen-mining-reports-q1-output-explores-sale-of-mexican-assets?source=tweet\" data-url=\"https://seekingalpha.com/news/3449233-mcewen-mining-reports-q1-output-explores-sale-of-mexican-assets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449231\" data-ts=\"1554809979\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IONS\" target=\"_blank\">IONS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449231-needham-likes-geron-in-premarket-analyst-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Needham likes Geron in premarket analyst action</a></h4><ul><li>Ionis Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a>) initiated with Neutral rating at Cantor Fitzgerald citing Spinraza headwinds.</li><li>Cerecor (NASDAQ:<a href='https://seekingalpha.com/symbol/CERC' title='Cerecor Inc.'>CERC</a>) initiated with Buy rating and $10 (93% upside) price target at Maxim Group. Shares up <font color=\"green\">2% </font>premarket.</li><li>BioMarin Pharmaceutical (NASDAQ:<a href='https://seekingalpha.com/symbol/BMRN' title='BioMarin Pharmaceutical Inc.'>BMRN</a>) resumed with Outperform rating and $110 (19% upside) price target at Raymond James.</li><li>Geron (NASDAQ:<a href='https://seekingalpha.com/symbol/GERN' title='Geron Corporation'>GERN</a>) upgraded to Buy with a $3 (63% upside) price target at Needham. Shares up <font color=\"green\">4%</font> premarket.</li><li>PerkinElmer (NYSE:<a href='https://seekingalpha.com/symbol/PKI' title='PerkinElmer, Inc.'>PKI</a>) upgraded to Buy with a $115 (15% upside) price target at Goldman Sachs.</li><li>Zogenix (NASDAQ:<a href='https://seekingalpha.com/symbol/ZGNX' title='Zogenix, Inc.'>ZGNX</a>) downgraded to Neutral with a $40 (23% downside risk) price target at Guggenheim after the FDA rejected its incomplete Fintepla application. Shares down <font color=\"red\">31% </font>premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449231\" data-linked=\"Needham likes Geron in premarket analyst action\" data-tweet=\"$IONS $BMRN $GERN - Needham likes Geron in premarket analyst action https://seekingalpha.com/news/3449231-needham-likes-geron-in-premarket-analyst-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3449231-needham-likes-geron-in-premarket-analyst-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449228\" data-ts=\"1554809822\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNGX\" target=\"_blank\">SNGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449228-ema-reaches-agreement-soligenix-for-sgx942-pip-shares-up-10-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EMA reaches agreement with Soligenix for SGX942 PIP; shares up 10% premarket</a></h4><ul><li>The Pediatric Committee &#40;PDCO&#41; of the EMA has <a href=\"https://seekingalpha.com/pr/17470185-soligenix-european-medicines-agency-pediatric-committee-reach-agreement-pediatric\" target=\"_blank\">agreed</a> to Soligenix's (NASDAQ:<a href='https://seekingalpha.com/symbol/SNGX' title='Soligenix, Inc.'>SNGX</a>) Pediatric Investigation Plan &#40;PIP&#41; for SGX942 (dusquetide). The Company may defer conducting the PIP until successful completion of Phase 3 clinical study evaluating SGX942 as a treatment for oral mucositis in patients with head and neck cancer &#40;HNC&#41;.</li>  <li>Following approval of the SGX942 Marketing Authorization Application for treatment of oral mucositis in adult patients with HNC, Soligenix will work with PDCO and EMA to include appropriate pediatric data in the approved labeling.</li>    <li>Dusquetide is an IDR, a new class of short, synthetic peptides.</li><li>Shares are up <font color=\"green\">10%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449228\" data-linked=\"EMA reaches agreement with Soligenix for SGX942 PIP; shares up 10% premarket\" data-tweet=\"$SNGX - EMA reaches agreement with Soligenix for SGX942 PIP; shares up 10% premarket https://seekingalpha.com/news/3449228-ema-reaches-agreement-soligenix-for-sgx942-pip-shares-up-10-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3449228-ema-reaches-agreement-soligenix-for-sgx942-pip-shares-up-10-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449227\" data-ts=\"1554809733\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PNR\" target=\"_blank\">PNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449227-pentairminus-2_8-after-slashing-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pentair -2.8% after slashing guidance</a></h4><ul><li>Pentair (NYSE:<a href='https://seekingalpha.com/symbol/PNR' title='Pentair plc'>PNR</a>) <font color=\"red\">-2.8%</font> premarket after its first-quarter results were \"significantly impacted\" by adverse weather in its higher-margin aquatics and ag-related businesses.</li><li>The company <a href=\"https://finance.yahoo.com/m/5ead7e57-e732-31bc-ba9a-fd77c9ace807/pentair-slashes-profit-and.html?siteid=yhoof2&amp;yptr=yahoo\" target=\"_blank\">cut</a> its Q1 adjusted EPS outlook to $0.43 (from a range of $0.52-$0.55) and expects sales to decline 6% to $689M (compared with previous guidance of flat to up 1%).</li><li>\"To start 2019, in addition to the adverse impact from weather, we have seen moderating growth in several of our end markets,\" said CEO John Stauch. \"We are also experiencing higher than anticipated inventory levels in some of our key distribution channels.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3449227\" data-linked=\"Pentair -2.8% after slashing guidance\" data-tweet=\"$PNR - Pentair -2.8% after slashing guidance https://seekingalpha.com/news/3449227-pentairminus-2_8-after-slashing-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3449227-pentairminus-2_8-after-slashing-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449220\" data-ts=\"1554808835\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449220-u-s-steel-downgraded-credit-suisse-on-weaker-competitive-position\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Steel downgraded at Credit Suisse on &#39;weaker competitive position&#39;</a></h4><ul><li>U.S. Steel (NYSE:<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a>) <font color=\"red\">-3.7%</font> pre-market after Credit Suisse <a href=\"https://www.streetinsider.com/Analyst+Comments/Credit+Suisse+Downgrades+US+Steel+%28X%29+to+Underperform%3B+Weak+Position+Ahead+of+Sheet+Tsunami/15352634.html\" target=\"_blank\">downgrades</a> shares to Underperform from Neutral and cuts its stock price target to a Street-low $13 from $21, saying the company was \"in a weaker competitive position\" relative to its peers.</li><li>U.S. Steel's EBITDA outlook is \"highly concerning given still high lagged sheet prices and a significant raw material squeeze ahead for Europe,\" analyst Curt Woodworth writes.</li><li>Credit Suisse discusses a \"Sheet Tsunami\" - a wave of low-cost supply  increases in 2021-22 - that will be \"very bearish\" for the  company.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449220\" data-linked=\"U.S. Steel downgraded at Credit Suisse on &#39;weaker competitive position&#39;\" data-tweet=\"$X - U.S. Steel downgraded at Credit Suisse on &#39;weaker competitive position&#39; https://seekingalpha.com/news/3449220-u-s-steel-downgraded-credit-suisse-on-weaker-competitive-position?source=tweet\" data-url=\"https://seekingalpha.com/news/3449220-u-s-steel-downgraded-credit-suisse-on-weaker-competitive-position\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449207\" data-ts=\"1554806993\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BCDA\" target=\"_blank\">BCDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449207-biocardia-readies-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioCardia readies equity offering</a></h4><ul><li>BioCardia (<a href='https://seekingalpha.com/symbol/BCDA' title='BioCardia, Inc.'>OTCQB:BCDA</a>) has filed a <a href=\"https://www.sec.gov/Archives/edgar/data/925741/000143774919006765/bcda20190405_s1.htm\" target=\"_blank\">preliminary prospectu</a>s for a public offering of units, each consisting of one common share and one warrant. Prices, volumes and terms have yet to be released.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449207\" data-linked=\"BioCardia readies equity offering\" data-tweet=\"$BCDA - BioCardia readies equity offering https://seekingalpha.com/news/3449207-biocardia-readies-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3449207-biocardia-readies-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449205\" data-ts=\"1554806776\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVS\" target=\"_blank\">NVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449205-novartis-completes-alcon-spin-off\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novartis completes Alcon spin-off</a></h4><ul><li>Novartis (NYSE:<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a>) has <a href=\"https://www.novartis.com/news/media-releases/novartis-continues-transformation-leading-medicines-company-completion-alcon-spin\" target=\"_blank\">completed </a>the spin-off of eye care devices unit Alcon via a dividend-in-kind distribution to NVS shareholders who received one Alcon share for every five NVS shares or ADRs held on April 8.</li><li>NVS plans to update investors on its strategic priorities and outlook during its annual Meet Novartis Management event in Cambridge, MA on May 22-23.</li><li><strong>Update</strong>: NVS is down <font color=\"red\">10%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449205\" data-linked=\"Novartis completes Alcon spin-off\" data-tweet=\"$NVS - Novartis completes Alcon spin-off https://seekingalpha.com/news/3449205-novartis-completes-alcon-spin-off?source=tweet\" data-url=\"https://seekingalpha.com/news/3449205-novartis-completes-alcon-spin-off\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449203\" data-ts=\"1554806153\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VXRT\" target=\"_blank\">VXRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449203-vaxart-down-35-after-pricing-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vaxart down 35% after pricing equity offering</a></h4><ul> <li>Vaxart (NASDAQ:<a href='https://seekingalpha.com/symbol/VXRT' title='Vaxart, Inc.'>VXRT</a>) has <a href=\"https://seekingalpha.com/pr/17470136-vaxart-announces-pricing-underwritten-public-offering\" target=\"_blank\">priced</a> its public offering of 9.1M common shares (including pre-funded warrants to purchase up to 8.2M common stock), and common warrants to purchase the same amount of shares at $1.10 per share and warrant, for gross proceeds of ~$10M.</li>     <li>Each warrant will have an exercise price of $1.10 per share and will expire five years from the date of       issuance.</li><li>Underwriters over-allotment is an additional 1,363,636 shares and/or warrants.</li><li>Closing date is April       11.</li><li>Shares are down <font color=\"red\">35%</font> premarket.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3449203\" data-linked=\"Vaxart down 35% after pricing equity offering\" data-tweet=\"$VXRT - Vaxart down 35% after pricing equity offering https://seekingalpha.com/news/3449203-vaxart-down-35-after-pricing-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3449203-vaxart-down-35-after-pricing-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:35 AM </div></div></li>","count":70,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}